curriculum vitae name xianglin l. du, mb, ms, phd · pdf filecurriculum vitae update: october...
TRANSCRIPT
C.V. for Xianglin Du, Ph.D.
Page 1 of 40
CURRICULUM VITAE
Update: October 5, 2017
NAME: Xianglin L. Du, MB, MS, PhD
PRESENT POSITION Professor of Epidemiology
& ADDRESS: School of Public Health
Department of Epidemiology, Human Genetics, and Environmental Sciences
The University of Texas Health Science Center at Houston (UTHealth)
1200 Pressler Street, RAS-E631
Houston, Texas 77030, USA.
Tel: (713) 500 9956; Fax: (713) 500 9264
E-mail: [email protected]
EDUCATION:
Sep. 1979 – June 1984 MB (Bachelor of Medicine) in Medicine
Medical School/School of Public Health
Anhui Medical University, China.
Sep. 1984 – June 1987 MS (Master of Science) in Clinical Epidemiology
School of Health Services Management
Anhui Medical University, China.
July 1990 – June 1991 World Health Organization Fellow
School of Medicine and Health Sciences
University of Newcastle-upon-Tyne, England, UK.
May 1993 – June 1993 Visiting Research Fellow, Division on Aging
Harvard University Medical School
Boston, Massachusetts, USA.
July 1993 – Jan. 1997 Ph.D. in Epidemiology and Public Health
School of Epidemiology and Health Sciences
University of Manchester Medical School, England, UK.
EMPLOYMENT AND POSITIONS HELD:
Sep. 2012 – present: Professor (with Tenure), Department of Epidemiology, Human Genetics, and Environmental
Sciences, School of Public Health, University of Texas Health Science Center (UTHealth), Houston, Texas, USA.
Jan. 2004 – Aug. 2012: Associate Professor (on Tenure-Track in 2004-2009 and with Award of Tenure effective
from September 1, 2009), Division of Epidemiology, Human Genetics & Environmental Sciences (primary appointment),
with membership in the Center for Health Services Research (since March 2004), adjunct Faculty in the UT-Graduate
School of Biomedical Sciences (since September 2007), and secondary Faculty appointment in the Division of
Management, Policy and Community Health (since June 2008), School of Public Health, University of Texas Health
Science Center, Houston, Texas, USA.
Sep. 2000 – Dec. 2003: Assistant Professor (on Tenure-Track), Department of Internal Medicine, with adjunct
faculty appointment in the Department of Preventive Medicine and Community Health, Associate Member of the
Graduate School of Biomedical Sciences, and Fellow of the Sealy Center on Aging, University of Texas Medical Branch,
Galveston, Texas, USA.
C.V. for Xianglin Du, Ph.D.
Page 2 of 40
Jul. 1999 – Aug. 2000: Assistant Professor (on Non Tenure-Track), Department of Internal Medicine, University
of Texas Medical Branch, Galveston, Texas, USA.
Feb. 1997 – Jun. 1999: Postdoctoral Fellow and Epidemiologist, Sealy Center on Aging, University of Texas
Medical Branch, Galveston, Texas, USA.
July 1993 – Jan. 1997: Research Fellow and Ph.D. candidate, East Lancashire stroke prevention project, School of
Epidemiology & Health Sciences, University of Manchester Medical School, England.
July 1993 – June 1995: Clinical Research Fellow, Manchester Center, International Case-Control Study of Low-
dose Oral Contraceptives & Women Health, Univ. of Manchester Medical School, England.
May – June 1993: Visiting Research Fellow, Division on Aging, Harvard University Medical School, Boston,
Massachusetts, USA.
July 1990 – Apr. 1993: World Health Organization Fellow and Research fellow, The Assessment of Outcomes of
Health Care in the Elderly, Departments of Medicine (Geriatrics), and Public Health and Epidemiology, University of
Newcastle upon Tyne, England.
July 1987 – June 1990: Instructor, Department of Social Medicine and Clinical Epidemiology, Anhui Medical
University, China.
Sep. 1984 – June 1987: Graduate Research Assistant, Department of Social Medicine and Clinical Epidemiology,
Anhui Medical University, China.
HONORS AND AWARDS:
Research Awards:
1990 World Health Organization Fellowship Award (1990-91).
1996 International Epidemiology Association Travel Scholarship Award.
2000 First prize award, poster presentations, Annual Health Services and Outcomes Research
Conference, Houston, Texas, USA, November 3, 2000.
2004 Excellence in Research Award, Univ. of Texas School of Public Health, Houston, Texas, USA.
2005 Excellence in Research Award, Univ. of Texas School of Public Health, Houston, Texas, USA.
2006 Excellence in Research Award, Univ. of Texas School of Public Health, Houston, Texas, USA.
2006 Best abstracts award (selected from over 1,600), paper entitled “Racial Disparities and
Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage
Prostate Cancer” at the AcademyHealth Annual Research Meeting, June 2006, Seattle, WA.
2007 Excellence in Research Award, Univ. of Texas School of Public Health, Houston, Texas, USA.
2008 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2009 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2010 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2011 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2012 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2013 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2014 Excellence in Research Incentive Award, UTHealth-School of Public Health, Houston, Texas, USA.
2015 Excellence in Research Incentive Award, UTHealth-School of Public Health, Houston, Texas, USA.
2016 Excellence in Research Incentive Award, UTHealth-School of Public Health, Houston, Texas, USA.
Teaching Awards:
2008 John P. McGovern Outstanding Teacher for 2008, ‘Teacher of the Year’, selected by the students of the
University of Texas (UT) School of Public Health, Houston, Texas, USA.
2009 Dean’s Teaching Excellence Award, UT-School of Public Health, Houston, Texas, USA.
2010 Dean’s Teaching Excellence Award, UT-School of Public Health, Houston, Texas, USA.
C.V. for Xianglin Du, Ph.D.
Page 3 of 40
2012 Academic (Teaching and Service) Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2013 Academic (Teaching and Service) Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2014 Academic (Teaching and Service) Incentive Award, UTHealth-School of Public Health, Texas, USA.
2015 Academic (Teaching and Service) Incentive Award, UTHealth-School of Public Health, Texas, USA.
2016 Academic (Teaching and Service) Incentive Award, UTHealth-School of Public Health, Texas, USA.
PROFESSIONAL SERVICES:
I. Membership in Professional Societies:
Member of the British Society for Social Medicine (1996-2001)
Member of the American Association for Health Services Research (1998)
Member of the American Society for Epidemiologic Research (1998-2004)
Member of the Gerontological Society of America (1999-2003)
Member of the Academy for Health Services Research (2005-2008)
Member of American Heart Association and American Stroke Association (2008-2009)
II. Reviewer for the Peer-Reviewed Professional Journals (Regular, Periodic or Occasional Review):
Name of the Peer-Reviewed Journals Year of Service
1. Journal of Epidemiology & Community Health 1996 - present
2. American Journal of Managed Care 1997 - present
3. Journal of Aging and Health 1997 - present
4. Journal of Health Care for the Poor and Underserved 1997 - present
5. Medical Care 1999 - present
6. Cancer 1999 - present
7. Bio-Med Central Cancer 1999 - present
8. Annals of Epidemiology 2000 - present
9. Journal of Clinical Epidemiology 2000 - present
10. Journal of Clinical Oncology 2000 - present
11. Drugs & Aging 2001 - present
12. Public Library of Science 2001 - present
13. American Journal of Public Health 2004 - present
14. Journal of the National Cancer Institute 2005 - present
15. International Journal of Gynecological Cancer 2006 - present
16. Women’s Health Issues 2006 - present
17. Joint Commission Journal on Quality & Patient Safety 2007 - present
18. International Journal of Radiation Oncology, Biology, Physics 2007 - present
19. The Open Health Services & Policy Journal 2007 - present
20. Cancer Epidemiology, Biomarkers & Prevention 2007 - present
21. Social Science & Medicine 2008 - present
22. Journal of Health & Place 2008 - present
23. Journal of Surgical Oncology 2008 - present
24. Acta Oncologica 2008 - present
25. Clinical Medicine: Oncology 2008 - present
26. American Journal of Epidemiology 2009 - present
27. Radiation Oncology 2009 - present
28. Acta Obstetricia et Gynecologica Scandinavica 2009 - present
29. International Journal of Health Geographics 2009 - present
30. The Open Pharmocoeconomics & Health Economics Journal 2009 - present
31. JAMA Internal Medicine (formerly Archives of Internal Medicine) 2009 - present
32. Pharmacy and Therapeutics 2009 - present
33. Clinical Medicine Reviews in Oncology 2010 - present
C.V. for Xianglin Du, Ph.D.
Page 4 of 40
34. Therapeutics and Clinical Risk Management 2010 - present
35. Journal of the American Geriatrics Society 2010 - present
36. BMC Public Health 2010 - present
37. European Journal of Clinical & Medical Oncology 2010 - present
38. Value in Health 2010 - present
39. British Journal of Cancer 2011 - present
40. Journal of Immigrant and Minority Health 2011 - present
41. Journal of General Internal Medicine 2011 - present
42. American Journal of Men's Health 2011 - present
43. Breast Cancer Research and Treatment 2012 - present
44. Leukemia and Lymphoma 2012 - present
45. American Journal of Pharmacy Benefits 2012 - present
46. International Journal of Surgical Oncology 2012 - present
47. Archives of Gerontology and Geriatrics 2012 - present
48. Journal of Infection and Public Health 2013 - present
49. Clinical Cancer Research 2013 - present
50. Texas Public Health Journal 2013 - present
51. Annals of Internal Medicine 2013 - present
52. International Journal of Women's Health 2013 - present
53. Journal of Gerontology & Geriatric Research 2014 - present
54. Journal of Clinical Gastroenterology 2014 - present
55. Clinical and Experimental Medicine 2014 - present
56. PLOS ONE 2014 - present
57. Cancer Causes and Control 2014 - present
58. Gynecologic Oncology 2014 - present
59. Heart 2015 - present
60. Cancer Epidemiology 2015 - present
61. Expert Opinion on Drug Safety 2015 - present
62. International Journal of Oncology 2015 - present
63. Expert Review of Pharmacoeconomics & Outcomes Research 2015 - present
64. Pharmacoepidemiology and Drug Safety 2015 - present
65. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2015 - present
66. Mayo Clinic Proceedings 2015 - present
67. International Journal of Cancer 2016 - present
68. British Journal of Clinical Pharmacology 2017 - present
69. JCO Clinical Cancer Informatics 2017 - present
70. Ethnicity and Health 2017 - present
Title of the Textbooks Reviewed by Invitation Year of Service
71. “Epidemiology: An Introduction for Public Health Practitioners”
proposal for Delmar-Cengage Learning, Health Care Publishing
Sep.-Oct. 2009
72. “Epidemiologic Research Methods in Public Health Practice”
textbook for Jones and Bartlett Publishers
Nov.-Dec. 2011
III. Services and Committees outside the Institution and for Federal Agencies:
Name of the Committee/Service Role Date of Service
1. Clinical Medicine Section of the Gerontological Society of America
Annual Scientific Meeting
Reviewer of the
Abstracts
2001-2003
C.V. for Xianglin Du, Ph.D.
Page 5 of 40
2. Cancer Poster Session of the Gerontological Society of America 54th
Annual Scientific Meeting in Chicago, November 2001
Chair of the
Session
2001
3. Gerontological Society of America 54th Annual Scientific Meeting in
Chicago, November 2001 - Three sessions (End-of-Life, Pain, and
Physical Function).
Chair of the 3
sessions
2001
4. American Public Health Association (APHA) Annual
Scientific Meeting
Reviewer of the
Abstracts
2005, 2007, 2008
5. Research Advisory Panel, VA Parkinson’s Disease Research,
Education and Clinical Center (PADRECC) at Houston, VA Medical
Center and Baylor College of Medicine, Houston, TX
Member of the
Advisory Panel
March 2006 -
December 2008
6. Member of Advisory Committee to the Texas Cancer Registry (TCR)
and Member of Texas Cancer Data Work Group (TCDWG), TCR,
Texas Department of State Health Services
Member July 2007 –
May 2016
7. Peer-reviewed Journal: The Open Health Services & Policy Journal Member of
Editorial Board
November 2007 -
November 2010
8. CDC (Centers for Disease Control and Prevention) Review Panel Reviewer April-May 2008
9. CDC (Centers for Disease Control and Prevention) Review Panel Reviewer April-May 2009
10. Comparative Effectiveness Research on Cancer, American Association
for Cancer Research Annual Conference on Cancer Prevention
Research, December 6-9, 2009, Houston, Texas.
Chairperson of the
Special Session on
CER
December 2009
11. Agency for Healthcare Research and Quality (AHRQ) Special
Emphasis Panel (iADAPT; RFA-HS-10-004 (R18))
Reviewer March-April 2010
12. AHRQ Healthcare Technology and Decision Sciences (HTDS) Study
Section
Reviewer May-June 2010
13. Agency for Healthcare Research and Quality (AHRQ) Special
Emphasis Panel (RFA-HS-10-020 (R01))
Reviewer May-June 2010
14. Peer-reviewed Journal: BMC Public Health Editorial Board
Associate Editor
August 2010 -
April 2013
15. Research Grants Council Hong Kong, China Reviewer March-April 2011
16. Peer-reviewed Journal: Epidemiology – Open Access Editorial Board
Associate Editor
June 2011-
May 2015
17. Foundation for Polish Science, Poland Reviewer April-May 2012
18. PCORI (Patient Centered Outcomes Research Institute) Phase-2 Grant
Review Panel
Scientific
Reviewer
October-
November 2012
19. NIH Health Delivery and Methodologies Special Emphasis Panel
(SEP)
Reviewer January-March
2014
C.V. for Xianglin Du, Ph.D.
Page 6 of 40
20. 2014-2015 Komen Graduate Training in Disparities (GTDR) Grant
Full Applications
Scientific
Reviewer
January-February
2015
21. NIH Special Emphasis Panel (SEP) Reviewer May-June 2015
22. Cancer Research UK (United Kingdom) Reviewer July-August 2016
23. NIH Serious Adverse Drug Reaction Research Study Section Reviewer Feb.-March 2017
IV. Institutional and Community Services:
Name of the Committee/Service Role Term/Date of Service
1. Rehabilitation Science Core Faculty Committee,
University of Texas Medical Branch at Galveston
Member March 2002 - Dec. 2003
2. Admission Triage Committee, Division of Epidemiology, University of
Texas School of Public Health at Houston
Member July 2004 - August 2008
3. Curriculum Committee, Division of Epidemiology (now Department of
Epidemiology, Human Genetics, and Environmental Sciences),
University of Texas School of Public Health at Houston
Member Dec. 2004 - present
4. Faculty Search Committee for Health Services and Outcomes, Division
of Management, Policy and Community Health, SPH
Member 2005
5. Search Committee for Administrative Service Officer (ASO-III),
Division of Epidemiology, UT-SPH
Member August-October 2006
6. Sub-Committee on Teaching Assistant (TA) Allocation for
Epidemiology Courses, Division of Epidemiology, UT-SPH
Member July-August 2006
7. Advisory Committee of the UT-SPH Cancer Prevention &
Control Training & Career Development Program, Division of
Behavioral Science and Health Promotion, UT-SPH
Member April 2007 - present
8. IRB (Institutional Review Board) Committee (Committee for the
Protection of Human Subjects) of the University of Texas Health
Science Center in Houston
Member Sep. 2007 - Aug. 2016
(three 3-year terms)
9. Faculty Development Leave Committee,
University of Texas School of Public Health at Houston
Member September 2007 - Aug.
2009
10. Peer Review Panel of the UTSPH for the PRIME (Pilot Research
Investigations with Mentoring for Excellence) and Bridging and Near-
Miss Grant Funds, UT-SPH at Houston
Member September 2007 -
August 2009
(two-year term)
11. Search Committee for Four Epidemiology Faculty Positions, UTSPH Member May 2008 - June 2010
12. AAR Peer Reviewer for the UT-SPH Member Dec. 2008 - Jan. 2009
13. Search Committee for the Director of the Health Outcomes Research,
UTSPH
Member May 2009 - June 2010
C.V. for Xianglin Du, Ph.D.
Page 7 of 40
14. Faculty Search Committee – Comparative Effectiveness /Outcomes
Research (10 Positions), UTSPH
Member Nov. 2010 - Aug. 2011
15. ‘Cancer Epidemiology Concentration’ Program Working Group,
UTSPH
Member Oct. 2011 - July 2012
16. Epidemiology Preliminary Exam Committee Member Aug. 2012 - July 2014
17. UT-SPH School-wide Tenure and Promotion (T&P) Committee Co-Chair April 2013 - Jan. 2014
18. UT-SPH School-wide Tenure and Promotion (T&P) Committee Chair Feb. 2014 - Feb. 2015
19. Faculty Search Committee at UT-SPH Brownsville Regional Campus –
Epi+Behavioral Sci joint Faculty with focus on CER, UTSPH
Member July 2015 - March 2016
20. Search Committee for UT-SPH Dallas Regional Dean, UTSPH Member January - Sep. 2016
21. Epidemiology Preliminary Exam Committee Member Aug. 2016 - present
TEACHING ACTIVITIES:
Part-A: Teaching Responsibilities at UTMB in Galveston (in 1999-2003):
I. Class Teaching at UTMB (University of Texas Medical Branch at Galveston):
Co-Instructor, the course module PMCH6330 “Introduction to Epidemiology”, 1999 at UTMB.
Co-Instructor, the course module PMCH6330 “Introduction to Epidemiology”, 2001 at UTMB.
Co-Instructor, the course module PMCH6330 “Introduction to Epidemiology”, 2002 at UTMB.
Co-Instructor, the course module PMCH6330 “Introduction to Epidemiology”, 2003 at UTMB.
Guest Lecturer, the course module PMCH6330 “Introduction to Epidemiology”, 2004 at UTMB.
Lead Instructor: Module PMCH6215 “Epidemiologic Research Using Large Public Databases”,
Spring Semester 2002 (a new course created and taught) at UTMB.
Lead Instructor: Module PMCH6215 “Epidemiologic Research Using Large Public Databases”,
Fall Semester, 2003 at UTMB.
II. Mentoring and Committee Advising:
Mentor, for a second year clinical geriatric fellow, 1999.
Mentor, for a first year medical student on the Summer Medical Research Project, 2000.
Mentor, for a postdoctoral fellow (Max E. Otiniano, MD, MPH) on the minority aging
projects, March 2001 – August 2002.
Mentor, for a geriatric and oncology fellow (Cynthia Osborne, MD) on the breast cancer
research, August 2001 – July 2002.
Mentor, for a clinical oncologist (Dennie V. Jones, MD) working on the NIH minority
supplement grant, March 2002 – December 2003.
Part-B: Teaching Responsibilities at UTHealth in Houston (from January 2004 to present):
I. Class Teaching at UT-SPH (University of Texas School of Public Health):
Course Number and Name Role (% effort) Semester/
Year
Number of
students
1. PH2711-Advanced Epidemiologic Methods II
(guest lecture on the Cox survival analysis)
Guest Lecturer Spring 2004 19
C.V. for Xianglin Du, Ph.D.
Page 8 of 40
2. PH2998-Epidemiologic Research Using Claims-Based
Healthcare Data
Lead Instructor (100%) Fall 2004 10
3. PH2710-Advanced Epidemiologic Methods I Co-Instructor (10%) Fall 2004 44
4. PH2610-Introduction to Epidemiology Guest Lecturer Fall 2004 85
5. PMCH6215-Introduction to Epidemiology, UTMB Guest Lecturer Fall 2004 25
6. PH2710-Advanced Epidemiologic Methods I Co-Instructor (10%) Spring 2005 18
7. PH2711-Advanced Epidemiologic Methods II
(lecture on the Cox survival project)
Guest Lecturer Spring 2005 20
8. PH2998-Epidemiologic Study Using Claims-Based
Healthcare Data
Lead Instructor (100%) Fall 2005 10
9. PH2710-Advanced Epidemiologic Methods I Guest Lecturer Fall 2005 20
10. PH2710-Advanced Epidemiologic Methods I Co-Instructor (5%) Spring 2006 24
11. PH2610-Introduction to Epidemiology Lead Instructor (100%) Summer 2006 8
12. PH2710-Advanced Epidemiologic Methods I Co-Instructor (5%) Spring 2007 32
13. PH2610(ITV)-Introduction to Epidemiology Lead Instructor (100%) Summer 2007 12
14. PH2612-Introduction to Epidemiology for Majors Lead Instructor (100%) Fall 2007 41
15. PH2710-Advanced Epidemiologic Methods I Co-Instructor (5%) Spring 2008 42
16. PH2612-Introduction to Epidemiology for Majors Lead Instructor (100%) Fall 2008 34
17. PH2612-Introduction to Epidemiology for Majors Guest Lecturer Spring 2009 26
18. PH2612-Epidemiology I (ITV to all campuses) Lead Instructor (100%) Fall 2009 31
19. PH2612-Epidemiology I Guest Lecturer Spring 2010 18
20. PH2612-Epidemiology I (ITV to all campuses) Lead Instructor (100%) Fall 2010 56
21. PH2612-Epidemiology I Guest Lecturer Spring 2011 20
22. PH2612-Epidemiology I (ITV to all campuses) Lead Instructor (100%) Fall 2011 54
23. PH2612-Epidemiology I Guest Lecturer Spring 2012 17
24. PHM2612-Epidemiology I Lead Instructor (100%) Fall 2012 19
25. PHM2612-Epidemiology I Lead Instructor (100%) Fall 2013 18
26. PHD2711-Epidemiology IV (ITV to all campuses) Guest Lecturer Spring 2014 12
27. PHM2612-Epidemiology I Lead Instructor (100%) Fall 2014 35
28. PHD2990-Epidemiology Seminar (ITV to all
campuses)
Lead Instructor (50%) Fall 2014 14
29. PHM2612-Epidemiology I Lead Instructor (100%) Fall 2015 34
30. PHD2990-Epidemiology Seminar (ITV to all
campuses)
Lead Instructor (50%) Fall 2015 14
31. PHM2612-Epidemiology I Lead Instructor (100%) Fall 2016 24
32. PHD2990-Epidemiology Seminar (ITV to all
campuses)
Lead Instructor (50%) Fall 2016 12
33. PHM9996-Capstone Course (ITV to all campuses)Wed Lead Instructor (60%) Spring 2017 27
34. PHM9996-Capstone Course (ITV to all campuses)Thu Guest Lecturer Spring 2017 29
35. PHM9996-Capstone Course (ITV to all campuses) Guest Lecturer Summer 2017 40
36. PHM2612-Epidemiology I Lead Instructor (100%) Fall 2017 27
37. PHD2990-Epidemiology Seminar (ITV to all
campuses)
Lead Instructor (50%) Fall 2017 11
II. Individual Study (PH2999), Practicum (PH9997), Thesis (PH9998)/Dissertation (PH9999) Research:
Name of Students Degree Program
(major field)
Type of Teaching Credit
Hours
Semester/Year
1. Yan Xing PhD (health service) Individual Study 3 Summer 2004
2. Shenying Fang PhD (biostatistics) Practicum 3 Fall 2004
3. Liqian Liu MS (epidemiology) Individual Study 1 Summer 2005
4. Nidhi Rohatgi MS (epidemiology) Individual Study 3 Summer 2005
5. Matthew Shim PhD (epidemiology) Individual Study 4 Summer 2005
C.V. for Xianglin Du, Ph.D.
Page 9 of 40
6. Nidhi Rohatgi MS (epidemiology) Thesis Research 2 Fall 2005
7. Evette Toney PhD (epidemiology) Individual Study 1 Fall 2005
8. Dale Hardy PhD (epidemiology) Individual Study 2 Fall 2005
9. Laurens Holmes DrPH (epidemiology) Individual Study 1 Spring 2006
10. Evette Toney PhD (epidemiology) Individual Study 5 Spring 2006
11. Amit Habbu MPH (epidemiology) Thesis Research 3 Spring 2006
12. Nidhi Rohatgi MS (epidemiology) Thesis Research 3 Spring 2006
13. Laurens Holmes DrPH (epidemiology) Dissertation Research 1 Spring 2006
14. Laurens Holmes DrPH (epidemiology) Dissertation Research 1 Summer 2006
15. Shenying Fang PhD (biostatistics) Practicum 4 Fall 2006
16. Ravi Chopra MS (epidemiology) Practicum 3 Fall 2006
17. Michelle Lacour MPH (epidemiology) Thesis Research 3 Fall 2006
18. David Yang MPH (epidemiology) Practicum 3 Spring 2007
19. Michelle Lacour MPH (epidemiology) Practicum 3 Spring 2007
20. Emily Bettis MPH (epidemiology) Practicum 3 Spring 2007
21. Michelle Lacour MPH (epidemiology) Thesis Research 3 Spring 2007
22. Yi Min PhD (biostatistics) Individual Study 2 Summer 2007
23. Stephen Gruschkus PhD (health service) Individual Study 2 Summer 2007
24. David Yang MPH (epidemiology) Individual Study 1 Summer 2007
25. Jessica Sun PhD (biostatistics) Individual Study 2 Summer 2007
26. Sachin Kamble MPH (epidemiology) Practicum 3 Summer 2007
27. Michelle Lacour MPH (epidemiology) Thesis Research 3 Summer 2007
28. Sachin Kamble MPH (epidemiology) Thesis Research 3 Fall 2007
29. Chung-Yuan Hu PhD (epidemiology) Practicum 1 Fall 2007
30. Arica White PhD (epidemiology) Individual Study 3 Fall 2007
31. Ravi Chopra MS (epidemiology) Thesis Research 3 Fall 2007
32. Michelle Lacour MPH (epidemiology) Thesis Research 5 Fall 2007
33. Kavita Sail PhD (health service) Individual Study 3 Spring 2008
34. Chung-Yuan Hu PhD (epidemiology) Individual Study 3 Spring 2008
35. Rui Xia PhD (biostatistics) Individual Study 3 Spring 2008
36. Arica White PhD (epidemiology) Individual Study 1 Spring 2008
37. Robin Lacour MPH (epidemiology) Thesis Research 9 Spring 2008
38. Emily Bettis MPH (epidemiology) Thesis Research 3 Spring 2008
39. Sachin Kamble MPH (epidemiology) Thesis Research 3 Spring 2008
40. David Yang MPH (epidemiology) Thesis Research 3 Spring 2008
41. Ravi Chopper MS (epidemiology) Thesis Research 3 Spring 2008
42. Chung-Yuan Hu PhD (epidemiology) Practicum 1 Spring 2008
43. Brian Badgwell MS (epidemiology) Individual Study 1 Summer 2008
44. Joyce Li MPH (epidemiology) Practicum 3 Summer 2008
45. Brady Moffett MPH (epidemiology) Practicum 3 Summer 2008
46. Nadia Barahmani MS (epidemiology) Thesis Research 5 Summer 2008
47. Brian Badgwell MS (epidemiology) Thesis Research 2 Summer 2008
48. Joyce Li MPH (epidemiology) Thesis Research 3 Summer 2008
49. Sachin Kamble MPH (epidemiology) Thesis Research 3 Summer 2008
50. Arica White PhD (epidemiology) Dissertation Research 3 Summer 2008
51. Monawar Hosain PhD (epidemiology) Dissertation Research 3 Summer 2008
52. Judith Wendt PhD (epidemiology) Individual Study 3 Fall 2008
53. Beatrix Foldi PhD (epidemiology) Individual Study 3 Fall 2008
54. Joyce Li MPH (epidemiology) Individual Study 3 Fall 2008
55. Chung-Yuan Hu PhD (epidemiology) Practicum 2 Fall 2008
56. Rita Sheth MPH (epidemiology) Practicum 3 Fall 2008
57. Nadia Barahmani MS (epidemiology) Thesis Research 3 Fall 2008
58. Emily Bettis MPH (epidemiology) Thesis Research 3 Fall 2008
59. Chung-Yuan Hu PhD (epidemiology) Dissertation Research 3 Fall 2008
60. Arica White PhD (epidemiology) Dissertation Research 3 Fall 2008
61. Stephen Gruschkus PhD (epidemiology) Dissertation Research 3 Fall 2008
62. Joyce Li MPH (epidemiology) Individual Study 3 Spring 2009
C.V. for Xianglin Du, Ph.D.
Page 10 of 40
63. Chung-Yuan Hu PhD (epidemiology) Practicum 1 Spring 2009
64. David Yang MPH (epidemiology) Thesis Research 3 Spring 2009
65. Sachin Kamble MPH (epidemiology) Thesis Research 3 Spring 2009
66. Rita Sheth MPH (epidemiology) Thesis Research 3 Spring 2009
67. Brady Moffett MPH (epidemiology) Thesis Research 3 Spring 2009
68. Chung-Yuan Hu PhD (epidemiology) Dissertation Research 3 Spring 2009
69. Arica White PhD (epidemiology) Dissertation Research 3 Spring 2009
70. Stephen Gruschkus PhD (epidemiology) Dissertation Research 3 Spring 2009
71. Beatrix Foldi PhD (epidemiology) Dissertation Research 4 Spring 2009
72. Brady Moffett MPH (epidemiology) Thesis Research 3 Summer 2009
73. Arica White PhD (epidemiology) Dissertation Research 3 Summer 2009
74. Stephen Gruschkus PhD (epidemiology) Dissertation Research 3 Summer 2009
75. Michelle Ludwig PhD (epidemiology) Individual Study 4 Fall 2009
76. Brady Moffett MPH (epidemiology) Thesis Research 3 Fall 2009
77. Jessica Clague PhD (epidemiology) Dissertation Research 5 Fall 2009
78. Peter Abotchie DrPH (HPBS) Dissertation Research 3 Fall 2009
79. Chung-Yuan Hu PhD (epidemiology) Dissertation Research 3 Fall 2009
80. Michelle Ludwig PhD (epidemiology) Dissertation Research 5 Fall 2009
81. Brady Moffett MPH (epidemiology) Thesis Research 3 Spring 2010
82. Jessica Clague PhD (epidemiology) Dissertation Research 5 Spring 2010
83. Peter Abotchie DrPH (HPBS) Dissertation Research 4 Spring 2010
84. Chung-Yuan Hu PhD (epidemiology) Dissertation Research 3 Spring 2010
85. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Spring 2010
86. Chung-Yuan Hu PhD (epidemiology) Dissertation Research 1 Summer 2010
87. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Summer 2010
88. Chung-Yuan Hu PhD (epidemiology) Cancer Epi Using Medicare 2 Summer 2010
89. Zhannat Nurgalieva PhD (epidemiology) Cancer Disparity Research 3 Summer 2010
90. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Fall 2010
91. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 3 Spring 2011
92. Kathryn Kimbrough MPH in Epidemiology Practicum 3 Summer 2011
93. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 1 Summer 2011
94. Li Nan MS in Epidemiology Thesis Research 3 Fall 2011
95. Laitan O. Lansebe MPH in Epidemiology Practicum 3 Fall 2011
96. Adeniran A. Olaoya MPH in Epidemiology Practicum 3 Fall 2011
97. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 2 Fall 2011
98. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Fall 2011
99. Li Nan MS in Epidemiology Thesis Research 1 Spring 2012
100. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 2 Spring 2012
101. Saurav Suman MPH in Epidemiology Practicum 3 Spring 2012
102. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Summer 2012
103. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 2 Summer 2012
104. Saurav Suman MPH in Epidemiology Thesis Research 3 Summer 2012
105. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Fall 2012
106. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 1 Fall 2012
107. Tong, Liyue PhD (epidemiology) Dissertation Research 1 Fall 2012
108. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Spring 2013
109. Tong, Liyue PhD (epidemiology) Dissertation Research 3 Spring 2013
110. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Summer 2013
111. Jose Zevallos MPH (epidemiology) Individual Study 3 Summer 2013
112. Poonawalla, Insiya PhD (epidemiology) Dissertation Research 3 Fall 2013
113. Tong, Liyue PhD (epidemiology) Dissertation Research 3 Fall 2013
114. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Fall 2013
115. Mohammad Shakhatreh MPH in Epidemiology Thesis Research 3 Fall 2013
116. John Teke MS (Biostatistics) Thesis Research 1 Spring 2014
117. Poonawalla, Insiya PhD (epidemiology) Dissertation Research 3 Spring 2014
118. Mohammad Shakhatreh MPH in Epidemiology Thesis Research 3 Spring 2014
119. Tong, Liyue PhD (epidemiology) Dissertation Research 3 Spring 2014
C.V. for Xianglin Du, Ph.D.
Page 11 of 40
120. Wang, Xin PhD (pharmacy) at Univ. of Houston Individual Study 3 Spring 2014
121. Poonawalla, Insiya PhD (epidemiology) Dissertation Research 3 Fall 2014
122. Chi Nguyen PhD (epidemiology) Dissertation Research 3 Fall 2014
123. Chen Ying PhD (epidemiology) Individual Study 3 Fall 2014
124. Xerxes Nozer Pundole PhD (epidemiology) Dissertation Research 5 Spring 2015
125. Poonawalla, Insiya PhD (epidemiology) Dissertation Research 3 Spring 2015
126. Chi Nguyen PhD (epidemiology) Dissertation Research 3 Spring 2015
127. Chen Ying PhD (epidemiology) Dissertation Research 3 Spring 2015
128. Joshua Swan MPH in Epidemiology Thesis Research 3 Summer 2015
129. Xerxes N. Pundole PhD (epidemiology) Dissertation Research 4 Fall 2015
130. Chi Nguyen PhD (epidemiology) Dissertation Research 3 Fall 2015
131. Chen Ying PhD (epidemiology) Dissertation Research 3 Fall 2015
132. Shuangshuang Fu PhD (epidemiology Dissertation Research 3 Fall 2015
133. Xerxes N. Pundole PhD (epidemiology) Individual Study 4 Fall 2015
134. Xiaotao Zhang PhD (epidemiology) Individual Study 3 Fall 2015
135. Chi Nguyen PhD (epidemiology) Individual Study 2 Fall 2015
136. Kathy M. Abusager MPH in Epidemiology Practicum 3 Fall 2015
137. Aylin Tansel MPH in Epidemiology Thesis Research 3 Spring 2016
138. Joshua Swan MPH in Epidemiology Thesis Research 3 Spring 2016
139. Aylin Tansel MPH in Epidemiology Individual Study 3 Spring 2016
140. Xerxes N. Pundole PhD (epidemiology) Dissertation Research 2 Spring 2016
141. Chen Ying PhD (epidemiology) Dissertation Research 3 Spring 2016
142. Chi Nguyen PhD (epidemiology) Individual Study 3 Spring 2016
143. Xerxes N. Pundole PhD (epidemiology) Dissertation Research 3 Summer 2016
144. Chen Ying PhD (epidemiology) Dissertation Research 3 Summer 2016
145. Catherine Hambleton MPH in Epidemiology Practicum 1 Summer 2016
146. Aylin Tansel MPH in Epidemiology Thesis Research 3 Summer 2016
147. Shuangshuang Fu PhD (epidemiology Dissertation Research 2 Fall 2016
148. Christine N. Spencer PhD (epidemiology) Dissertation Research 1 Fall 2016
149. Xerxes N. Pundole PhD (epidemiology) Dissertation Research 3 Fall 2016
150. Chen Ying PhD (epidemiology) Dissertation Research 3 Fall 2016
151. Anand, Grace MPH in Epidemiology Practicum 3 Fall 2016
152. Chi Nguyen PhD (epidemiology) Dissertation Research 2 Fall 2016
153. Shuangshuang Fu PhD (epidemiology Dissertation Research 2 Spring 2017
154. Christine N. Spencer PhD (epidemiology) Dissertation Research 3 Spring 2017
155. Chi Nguyen PhD (epidemiology) Dissertation Research 3 Spring 2017
156. Puja Aggarwal PhD (epidemiology) Dissertation Research 3 Spring 2017
157. Shuangshuang Fu PhD (epidemiology) Individual Study 1 Spring 2017
158. Naruhiko Ikoma MS in Epidemiology Thesis Research 2 Summer 2017
159. Christine N. Spencer PhD (epidemiology) Dissertation Research 3 Summer 2017
160. Puja Aggarwal PhD (epidemiology) Dissertation Research 3 Summer 2017
161. Shuangshuang Fu PhD (epidemiology Practicum 2 Fall 2017
162. Tam, Samantha (MD) MPH in Epidemiology Thesis Research 3 Fall 2017
163. Chi Nguyen PhD (epidemiology) Dissertation Research 3 Fall 2017
164. Shuangshuang Fu PhD (epidemiology Dissertation Research 3 Fall 2017
165. Puja Aggarwal PhD (epidemiology) Dissertation Research 3 Fall 2017
III. Member of the Academic/Thesis/Dissertation Committees for Students:
Name of Students Degree Program
(type of doctoral committee)
Study Period Status or Month/Year of
Graduation
1. Lu Mei MS in Biostatistics (minor in Epi) Feb. 2004-Dec. 2004 Graduated in 12/2004
2. Kelly Merriman PhD in Epidemiology (dissertation) Sep. 2004-Nov.2007 Graduated in 11/2007
3. Liu Hui MS in Biostatistics (minor in Epi) Dec. 2004-Dec. 2005 Graduated in 12/2005
4. Liqian Liu MS in Epidemiology (thesis) Aug. 2004-Dec. 2005 Graduated in 12/2005
C.V. for Xianglin Du, Ph.D.
Page 12 of 40
5. Yan Xing PhD in Biostatistics (minor in Epi) Sep. 2004-Aug. 2006 Passed qualifying exam
6. Shenying Fang PhD in Biostatistics (minor in Epi) Dec. 2004-Mar. 2006 Passed qualifying exam
7. Zhigang Duan PhD in Biostatistics (minor in Epi) Jan. 2005-Feb. 2006 Passed qualifying exam
8. Liz Ye Han MPH in Biostatistics (thesis) Mar. 2004-Mar. 2006 Graduated in 03/2006
9. Prashant Gundre MPH in community health Aug. 2004-Aug. 2005 Moved away/discontinued
10. Catherine Gomez MPH in health promotion Aug. 2004-Nov. 2010 Graduated in 11/2010
11. Xuemei Wang PhD in Biostatistics (minor in Epi) Oct. 2004- Aug. 2006 Passed qualifying exam
12. Mai Pham MPH in Health Service and Policy Aug. 2005-Aug. 2006 Moved away/discontinued
13. Julie S. Beaver MS in Biostatistics (minor in Epi) Oct. 2004-Dec. 2005 Graduated in 12/2005
14. Kai Sun MS in Biostatistics (minor in Epi) Aug. 2005-Aug. 2006 Graduated in 08/2006
15. Rui Xia MS in Biostatistics (minor in Epi) Aug. 2005-Aug. 2007 Graduated in 08/2007
16. Tuan Vo PhD in Epidemiology (dissertation) Jan. 2005-Aug. 2006 Graduated in 08/2006
17. Monawar Hosain PhD in Epidemiology (dissertation) Aug. 2005-Aug. 2008 Graduated in 08/2008
18. Sandra Olfert PhD in Epidemiology (dissertation) Aug. 2005-Mar. 2006 Graduated in 03/2006
19. Desiree Jones PhD in Epidemiology (dissertation) Aug. 2005-May 2006 Graduated in 05/2006
20. Mala Pande PhD in Epidemiology (dissertation) Sep. 2006-Nov. 2007 Graduated in 11/2007
21. Liu Mei PhD in Biostatistics (minor in Epi) Jun. 2006-Mar. 2008 Passed qualifying exam
22. Yu-Feng Lin DrPH in Health Services (dissertation) Oct. 2006-Jul. 2009 Graduated in 07/2009
23. Han Liu PhD in Molecular Epi (from GSBS) Nov. 2006-May 2007 Graduated MS in 05/2007
24. Ashwini Mhatre MS in Epidemiology (thesis) Nov. 2006-Nov. 2008 Graduated in 11/2008
25. Javier Berrios-Rivera MS in Epidemiology Jan. 2007-Jan. 2009 Moved away/discontinued
26. Min Yi PhD in Biostatistics (minor in Epi) Jan. 2007-Feb. 2009 Passed qualifying exam
27. Jun Liu PhD in Biostatistics (minor in Epi) Jan. 2007-Oct. 2009 Passed qualifying exam
Jun Liu PhD in Biostatistics (dissertation) Jan. 2012-Nov. 2012 Graduated in 11/2012
28. Kaiyan Jing MS in Biostatistics (minor in Epi) Feb. 2007-Mar. 2008 Graduated in 03/2008
29. Matthew Shim PhD in Epidemiology (dissertation) Feb. 2007-Jan. 2008 Graduated in 01/2008
30. Abeer B. Alsarraj MS in Epidemiology (thesis) Feb. 2008-Oct. 2009 Graduated in 10/2009
31. Scott Stover PhD in Health Policy (minor in Epi) Apr. 2007-Apri. 2010 Changed the program
32. Dawen Sui PhD in Biostatistics (minor in Epi) Mar. 2008-Mar. 2011 Changed the program
33. Ning Zhang MS in Biostatistics (minor in Epi) Mar. 2008-May 2012 Graduated in 05/2012
34. Rui Xia PhD in Biostatistics (minor in Epi) Apr. 2008-Mar. 2010 Passed qualifying exam
35. Kavita Sail PhD in Health Services (dissertation) May 2008-Apr. 2010 Graduated in 04/2010
36. Sofia De achaval MS in Epidemiology (thesis) Oct. 2008-Aug. 2009 Graduated in 08/2009
37. Saqr Hatem PhD in Health Policy (minor in Epi) Dec. 2008-Jun. 2009 Passed qualifying exam
38. Caimiao Wei PhD in Biostatistics (minor in Epi) Jan. 2009-Sep. 2010 Passed qualifying exam
Caimiao Wei PhD in Biostatistics (dissertation) May 2012-May 2015 Graduated in 05/2015
39. Ma Long PhD in Biostatistics (minor in Epi) Apr. 2009-Apr. 2011 Passed qualifying exam
40. Liu Mei PhD in Biostatistics (dissertation) Aug. 2009-May 2010 Graduated in 05/2010
41. Wang Gangduo MS in Biostatistics (minor in Epi) Aug. 2009-May 2012 Graduated in 05/2012
42. Niu Jiangong MS in Biostatistics (minor in Epi) Oct. 2009-Oct. 2011 Changed the program
43. Judith Wendt (MS) PhD in Epidemiology (dissertation) Dec 2009- May 2012 Graduated in 05/2012
44. Zhang, Xuan PhD in Biostatistics (minor in Epi) Mar. 2010-Feb. 2011 Passed qualifying exam
45. Yi Cai MS in Biostatistics (minor in Epi) Apr. 2010-Aug. 2011 Graduated in 08/2011
46. Bo He PhD in Biostatistics (minor in Epi) Apr. 2010-Oct. 2011 Passed qualifying exam
47. Marc Kowalkowski MS in Epidemiology (thesis) June 2010-Nov. 2010 Graduated in 11/2010
48. Panchal, Janki M PhD in Health Economics (dissertation) Oct. 2010-May 2012 Graduated in 05/2012
49. Wang Ying MS in Biostatistics (minor in Epi) Oct. 2010-July 2011 Graduated in 07/2011
50. Aditi Kadakia MS in pharmacy (Univ. of Houston) Mar. 2011-Aug. 2011 Graduated in 08/2011
51. Wang, Tao PhD in Biostatistics (minor in Epi) April 2011-Oct. 2012 Graduated in 10/2012
52. Duong T. Tran PhD in Epidemiology (dissertation) Sep. 2011-July 2013 Graduated in 07/2013
53. Lee Cheng PhD in Biostatistics (dissertation) Nov. 2011-Nov. 2012 Graduated in 11/2012
54. Jinhai Huo PhD in Health Services (dissertation) Jan. 2012-May 2013 Graduated in 05/2013
55. Hong Zhang PhD in Biostatistics (dissertation) Mar. 2012-May 2013 Graduated in 05/2013
56. Russell, Heidi (MD) PhD in Health Services (dissertation) July. 2012- July 2013 Graduated in 07/2013
57. Park, Minjeong PhD in Biostatistics (dissertation) Aug. 2012-Dec. 2013 Graduated in 12/2013
58. Adhikari, Deepak MS in Biostatistics (minor in Epi) Aug. 2012-July 2013 Graduated in 07/2013
59. Malla, Rashmi MS in Biostatistics (minor in Epi) Sep. 2012- May 2013 Graduated in 05/2013
C.V. for Xianglin Du, Ph.D.
Page 13 of 40
60. Ling, Kok Yan MS in Biostatistics (minor in Epi) Oct. 2012- May 2013 Graduated in 05/2013
61. Yue Song MS in Biostatistics (minor in Epi) Jan. 2013-May 2013 Graduated in 05/2013
62. Yang Zhao MS in Biostatistics (minor in Epi) Jan. 2013-June 2013 Graduated in 06/2013
63. Marc Kowalkowski PhD in Epidemiology (dissertation) Feb. 2013-Aug. 2013 Graduated in 08/2013
64. John Teke MS in Biostatistics (minor in Epi) Feb. 2013-Aug. 2014 Graduated in 08/2014
65. Kim, Jung Hyun PhD in Health Services (dissertation) Aug. 2013-Dec. 2016 Graduated in 12/2016
66. Chung, Tong Han PhD in Health Services (dissertation) Aug. 2013-Aug. 2015 Graduated in 08/2015
67. Chuan Hong PhD in Biostatistics (dissertation) May 2014-May 2016 Graduated in 05/2016
68. Chuo, Ching-Yi PhD in Epidemiology (dissertation) Aug. 2014-Dec. 2016 Graduated in 12/2016
69. Rohan C. Parikh PhD in Health Services (dissertation) Aug. 2014-Aug. 2015 Graduated in 08/2015
70. Min-Ji Kwak DrPH in Health Services (dissertation) Nov. 2014-present
71. Maria A. Ukhanova PhD in Health Services (dissertation) Feb. 2015-present
72. Chen, Tsun-Hsuan (Joy) PhD in Environmental Sci(dissertation) Oct. 2015-present
73. Nancy M. Wood (MS) PhD in Health Services (dissertation) Oct. 2016-present
IV. Advisor and/or Supervisor of Academic/Thesis/Dissertation Committees for Students:
Name of Students
(degree before entry)
Degree Program
(type of doctoral committee)
Study Period Status or Month/Year
of Graduation*
1. Nidhi Rohatgi (MD) MS in Epidemiology (thesis) Aug. 2004-May 2006 Graduated in 05/2006
2. Laurence Holmes (MD, MPH) DrPH in Epidemiology (qualifying) Aug. 2004-Jan. 2006 Passed qualifying exam
Laurence Holmes (MD, MPH) DrPH in Epidemiology(dissertation) Jan. 2006-Aug. 2006 Graduated in 08/2006
3. Thanh Q. Tran (MS) PhD in Epidemiology (qualifying) Aug. 2004-Mar. 2007 Passed qualifying exam
4. Amit Habbu (MBBS) MPH in Disease Control Jan. 2005-Jun. 2006 Left for residence training
5. Evette Toney (MPH) PhD in Epidemiology (qualifying) Jan. 2005-Feb. 2006 Passed qualifying exam
6. Judith Wendt (MS) PhD in Epidemiology (qualifying) Jan. 2005-May 2009 Passed qualifying exam
7. Michelle Lacour (BS) MPH in Epidemiology (thesis) Aug. 2005-Nov. 2007 Graduated in 11/2007
8. Ravi Chopra (MD) MS in Epidemiology Aug. 2005-Jun. 2008 Moved away/discontinued
9. Beatrix Foldi (MD) PhD in Epidemiology (qualifying) Aug. 2005-Jul. 2008 Passed qualifying exam
10. Nadia Baramani (MD) MS in Epidemiology (thesis) Aug. 2005-Nov. 2008 Graduated in 11/2008
11. Emily Bettis (BS) MPH in Epidemiology (thesis) Jan. 2006-Nov. 2008 Graduated in 11/2008
12. Sachin Kamble (MD) MPH in Epidemiology Jan. 2006-Jan. 2010 Moved away/discontinued
13. Christian Gutierrez (MPH) PhD in Epidemiology (qualifying) Jun. 2006-Jun. 2009 Moved away/discontinued
14. Sarah Duong (BS) MPH in Epidemiology Aug. 2006-Jul. 2007 Transferred for MD/MPH
15. David Yang (BS) MPH in Epidemiology (thesis) Aug. 2006-Apr. 2009 Graduated in 04/2009
16. Chung-Yuan Hu (MPH) PhD in Epidemiology (qualifying) Aug. 2006-Feb. 2008 Passed qualifying exam
Chung-Yuan Hu (MPH) PhD in Epidemiology (dissertation) Mar. 2008-Aug. 2010 Graduated in 08/2010
17. Jonas De Souza (MD fellow) MS in Epidemiology Jan. 2007-Jan. 2009 Transferred to U. Chicago
18. Joyce Li (MD fellow) MPH in Epidemiology (thesis) Jan. 2007-Apr. 2009 Graduated in 04/2009
19. Robin A. Lacour (MD fellow) MPH in Epidemiology (thesis) Jul. 2007-Mar. 2008 Graduated in 03/2008
20. Larissa Meyer (MD fellow) MPH in Epidemiology Aug. 2007-Mar. 2008 Changed to genetic epi
21. Rita Sheth (MD fellow) MPH in Epidemiology (thesis) Aug. 2007-Apr. 2009 Graduated in 04/2009
22. Jessica Clague (MS) PhD in Epidemiology (qualifying) Aug. 2007-May 2009 Passed qualifying exam
Jessica Clague (MS) PhD in Epidemiology (dissertation) May 2009-Apr. 2010 Graduated in 04/2010
23. Brady Moffett (PharmD) MPH in Epidemiology (thesis) Jan. 2008-Apr. 2010 Graduated in 04/2010
24. Brian Badgwell (MD fellow) MS in Epidemiology (thesis) Jan. 2008-Aug. 2008 Graduated in 08/2008
25. Arica White (MPH) PhD in Epidemiology (dissertation) Mar. 2008-Aug. 2009 Graduated in 08/2009
26. Zhannat Nurgalieva (MD, MPH) PhD in Epidemiology (qualifying) Aug. 2008-June 2010 Passed qualifying exam
Zhannat Nurgalieva (MD, MPH) PhD in Epidemiology (dissertation) June 2010-Nov. 2012 Graduated in 11/2012
27. Michelle Ludwig (MD, MPH) PhD in Epidemiology (qualifying) Aug. 2008-Aug. 2009 Passed qualifying exam
Michelle Ludwig (MD, MPH) PhD in Epidemiology (dissertation) Aug. 2009-Dec. 2013 Graduated in 12/2013
28. Stephen Gruschkus (MPH) PhD in Epidemiology (dissertation) Oct. 2008-Aug. 2009 Graduated in 08/2009
29. Daniel A. Anaya (MD) MPH in Epidemiology Jan. 2009-Jan. 2012 Moved away/discontinued
30. Peter N. Abotchie (MPH) DrPH in HPBS (dissertation) Jun. 2009-May 2010 Graduated in 05/2010
C.V. for Xianglin Du, Ph.D.
Page 14 of 40
31. Ali Mazloom (MD) MPH in Epidemiology Aug. 2009-Aug. 2010 Transferred to another U.
32. Kathryn A. Kimbrough (MD) MPH in Epidemiology (capstone) Aug. 2010-May 2012 Graduated in 05/2012
33. Li Nan (MD) MS in Epidemiology (thesis) Aug. 2010-May 2012 Graduated in 05/2012
34. Laitan O. Lansebe (BS) MPH in Epidemiology (thesis) Aug. 2010-May 2012 Graduated in 05/2012
35. Olaoya, Adeniran A (MD) MPH in Epidemiology (capstone) Oct. 2010-May 2012 Graduated in 05/2012
36. Suman, Saurav (MD) MPH in Epidemiology (capstone) Dec. 2010-Jan. 2014 Graduated in 05/2014
37. Yucel, Emre (BS, MS) PhD in Epidemiology (qualifying) Aug. 2011-Dec. 2011 Changed the program
38. Luis J. Garcia Morales (MD) MS in Epidemiology Jan. 2012-May 2014 Changed the program
39. Alaina J. Brown (MD) MPH in Epidemiology (capstone) Aug. 2012-Jan. 2014 Graduated in 05/2014
40. Mohammad Shakhatreh (MD) MPH in Epidemiology (thesis) Aug. 2012-May 2014 Graduated in 05/2014
41. Tong, Liyue (MS) PhD in Epidemiology (dissertation) Oct. 2012-Jan. 2014 Graduated in 01/2014
42. Poonawalla, Insiya B (MPH) PhD in Epidemiology (dissertation) Dec. 2012-May 2015 Graduated in 05/2015
43. Chen Ying (MS) PhD in Epidemiology (qualifying) Aug. 2013-Jan. 2014 Passed prelim-exam
Chen Ying (MS) PhD in Epidemiology (dissertation) Feb. 2014-Dec. 2016 Graduated in 12/2016
44. Shuangshuang Fu (MS) PhD in Epidemiology (qualifying) Aug. 2013-July 2015 Passed prelim-exam
Shuangshuang Fu (MS) PhD in Epidemiology (dissertation) Aug. 2015-present
45. Xerxes N. Pundole (MD, MPH) PhD in Epidemiology (qualifying) Aug. 2013-July 2014 Passed prelim-exam
Xerxes N. Pundole (MD, MPH) PhD in Epidemiology (dissertation) Aug. 2014-Dec. 2016 Graduated in 12/2016
46. Anand, Grace Shebha (MD) MPH in Epidemiology (capstone) Jan. 2014-May 2017 Graduated in 05/2017
47. Chi Nguyen (MPH) PhD in Epidemiology (dissertation) Jan. 2014-present
48. Xiaotao Zhang (MD, MS) PhD in Epidemiology (qualifying) Aug. 2014-July 2016 Passed prelim-exam
49. Joshua Swan (MS) MPH in Epidemiology (thesis) Aug. 2014-May 2016 Graduated in 05/2016
50. Aylin Tansel (MD) MPH in Epidemiology (thesis) Aug. 2014-Dec. 2016 Graduated in 12/2016
51. Abhinav Dodeja (MD) MPH in Epidemiology Aug. 2014-present
52. Kathy M. Abusager (BS) MPH in Epidemiology (capstone) Feb. 2015-Dec. 2015 Graduated in 12/2015
53. Catherine Hambleton (MD) MPH in Epidemiology (capstone) Aug. 2015-May 2017 Graduated in 05/2017
54. Alexia Wilson (BA) MPH in Epidemiology Jan. 2016-present
55. Christine N. Spencer (MPH) PhD in Epidemiology (dissertation) Jun. 2016-present
56. Ikoma, Naruhiko (MD) MS in Epidemiology (thesis) Aug. 2016-Aug. 2017 Graduated in 08/2017
57. Tam, Samantha (MD) MPH in Epidemiology (thesis) Aug. 2016-present
58. Nair, Mrudula (BDS) MPH in Epidemiology Aug. 2016-present
59. Smith, Robert (BS) MPH in Epidemiology Aug. 2016-present
60. Puja Aggarwal (BDS) PhD in Epidemiology (dissertation) Sep. 2016-present
RESEARCH ACTIVITIES:
I. Major Areas of Research Interest:
Clinical Epidemiology, Epidemiology of Cardiovascular Diseases, Epidemiology of Cancer, Health Services Research,
Outcomes Research, Breast Cancer Outcomes Research, Nationwide Medicare Claims-Based Research, Disease
Registries (cancer and stroke), Patterns of Care Studies, Evaluating the Effectiveness of Health Services and Therapies,
Comparative Effectiveness Research on Health Services/Therapies, Disparities in Healthcare and Outcomes, and
Postmarketing Drug Surveillance of Adverse-Effects or Toxicities.
II. Research Grant Support:
Active Grants:
1. Grant Title: “Impact of Health Insurance on Racial Disparities in Cancer Screening, Diagnosis, Treatment and
Survival in Texas”
PI: Du, Xianglin L. at UT-SPH; Agency: CPRIT (Cancer Prevention and Research Institute of Texas);
Type and Grant Number: Individual Investigator Research Award-RP130051;
Period: 06/01/13 - 11/30/17; Total cost: $435,049; Effort: 25%;
Role: PI.
2. Grant Title: “Graduate Training Program in Breast Cancer Disparities at UTSPH”
C.V. for Xianglin Du, Ph.D.
Page 15 of 40
PI: Dr. Sally Vernon at UT-SPH; Agency: Susan J. Komen for the Cure Foundation;
Type: Training grant - GTDR14300827; Period: 10/30/14 - 10/29/17; Total cost: $135,000; Effort: 5.5%.
Role: Co-Investigator and Mentor.
3. Grant Title: “Graduate Training Program in Breast Cancer Disparities at UTSPH”
PI: Dr. Sally Vernon at UT-SPH; Agency: Susan J. Komen for the Cure Foundation;
Type: Training grant - GTDR17497435; Period: 10/30/17 - 10/29/20; Total cost: $135,000; Effort: 5.5%.
Role: Co-Investigator and Mentor.
4. Grant Title: “Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics”
PI: Dr. Hua Xu; Type and Grant Number: NIH-NCI 1U24 CA194215-01A1;
Period: 09/01/2016 – 08/31/2021; Total costs: $679,300; Effort: 5%;
Role: Co-Investigator.
5. Grant Title: “Behavioral Science Education Cancer Prevention/Control”
PI: Dr. Mullen, Patricia at UT-School of Public Health; Agency: NIH/NCI;
Type: 2R25-CA057712-21; Period: 09/01/13 - 08/31/18; Total cost: $537,192 per year;
Effort: Serving on advisory board and mentor with no salary support.
Role: Advisory Board Member and Mentor.
6. Grant Title: “Research Training in Gasteroenterology”
PI: Dr. Hashem B. El-Serag at Baylor College of Medicine; Agency: NIH/NIDDK;
Type and Grant Number: 2T32DK083266-06; Total cost: $144,277 per year;
Period: 05/01/15 - 04/31/20; Effort: Serving as mentor with no salary support.
Role: Mentor.
Completed Grants:
7. Grant Title: “Comparative Effectiveness and Cost Effectiveness of Cancer Chemotherapy”
PI: Du, Xianglin L. at UT-SPH; Agency: AHRQ; Type: R01-HS018956-01A1;
Period: 04/01/12 - 01/31/17; Total cost: $880,026; Effort: 25%.
Role: PI.
8. Grant Title: “Postmarketing Surveillance of Toxicities Associated with Cancer Chemotherapy”
PI: Xianglin Du; Agency: AHRQ; Type: R01-HS016743-01;
Period: 04/01/07-03/31/12; Total cost: $979,451; Effort: 30%.
Role: PI.
9. Grant Title: “Evaluation of Chemotherapy Claims for Breast Cancer”
PI: Xianglin Du; Agency: NIH/NCI; Type: R01-CA090626-01;
Period: 03/01/01-02/28/06; Total cost: $704,025. Effort: 30% average per year during the study period.
Role: PI.
10. Grant Title: “Research Supplement for Underrepresented Minorities”
PI: Xianglin Du; Agency: NIH/NCI; Type: R01-CA090626-S1;
Period: 03/01/02-01/31/04; Total cost: $316,394. (Note: This grant was to support Dennie Jones, MD, Associate
Professor of Medicine in the Division of Oncology, Department of Internal Medicine to do clinical epidemiology
and health service research, 50% of his efforts).
Role: PI.
11. Grant Title: “Impact of Axillary Dissection on Clinical Outcomes of Breast Cancer Surgery”
PI: Xianglin Du; Agency: U.S. Department of Defense; Type: DAMD17-99-1-9379;
Period: 06/01/99-06/31/01; Total cost: $83,802. Effort: 20%.
Role: PI.
C.V. for Xianglin Du, Ph.D.
Page 16 of 40
12. Grant Title: “Variations in Breast Cancer Treatment and Mortality”
PI: JS Goodwin; Agency: NIH/NCI; Type: R01-CA871773;
Period: 06/01/99-05/31/03; Total cost: $1,129,632. Effort: 40%.
Role: Co-investigator. 13. Grant Title: “Use of Claims Data to Study Quality of Cancer Care”
PI: JS Goodwin; Agency: NIH/NCI; Type: R01;
Period: 12/01/03-11/30/07; Total cost: $792,750. Effort: 50%.
Role: Co-investigator (moved to the UT-Houston one month after the study was funded). 14. Grant Title: “Understanding Disparities in Cervical Cancer Survival”
PI: Ann Coker; Agency: NIH/NCI; Type: R21-CA114330;
Period: 04/01/05-03/31/08; Total cost: $392,769; Effort: 5%.
Role: Co-investigator. 15. Grant Title: “Southwest Center for Occupational and Environmental Health”
PI: Sarah Felknor (former PI: George Delclos); Agency: CDC; Type: 1T42OH008421-01;
Period: 07/01/05-06/30/10; Total Cost: $1,263,791. Effort: 5%.
Role: Co-investigator. 16. Grant Title: “Evaluating the Utilization of Screening for Hepatocellular Carcinoma”
PI: Dr. Jessica A. Davila; Agency: American Cancer Society; Type: RSGDB-07-010-01-CPHPS;
Period: 01/01/07-12/31/09; Total cost: $352,000; Effort: 15%.
Role: Co-investigator (PI for subcontract with the Baylor College of Medicine at Houston). 17. Grant Title: “Effective Surveillance Strategies for Melanoma Patients”
PI: Dr. Cormier, Janice at UT-MDACC; Agency: NIH/NCI; Type: R01-CA127328-01A1;
Period: 12/01/07-11/30/10 (NC extension to 11/30/2012); Total cost: $878,508; Effort: 10%.
Role: Co-Investigator (PI for subcontract with the UT-MD Anderson Cancer Center at Houston). 18. Grant Title: “Batterer Psychological Profile--Preventing Partner Abuse”
PI: Ann Coker; Agency: CDC; Type: R49CE000606;
Period: 03/01/08-08/31/09; Total cost: $285,941; Effort: 5.5%.
Role: Co-investigator (PI for subcontract with the University of Kentucky at Lexington). 19. Grant Title: “Finding Vulnerable Populations in the Community and Their Special Needs for Public Health
Emergency Preparedness Using Medicaid and Medicare Data”
PI: Liu, Leanne at the Houston Department of Health and Human Services;
Agency: Texas Department of Health and Human Services and Centers for Disease Control & Prevention;
Type: Public Health Emergency Preparedness Award;
Period: 07/01/10-06/31/11; Total cost: $151,793; Effort: 10%;
Role: Co-Investigator. 20. Grant Title: “Texas Breast Cancer Screening, Early Detection and Treatment Program Outcomes Study”
PI: Dr. Begley, Charles at UT-SPH; Agency: CPRIT (Cancer Prevention and Research Institute of Texas); Type:
Innovation Awards for Cancer Prevention Programs and Services-PP100124;
Period: 08/01/10-01/31/12; Total cost: $138,768; Effort: 10%;
Role: Co-Investigator. 21. Grant Title: “CERCIT: Comparative Effectiveness Research On Cancer in Texas”
PI: Dr. Goodwin, JS at UTMB; Agency: CPRIT (Cancer Prevention and Research Institute of Texas);
Type: Multi-Investigator Award-RP101207; Period: 8/1/10-7/31/13; Total cost: $4,861,175; Effort: 10%;
Role: Co-Investigator (one core project) and Mentor (on training core).
C.V. for Xianglin Du, Ph.D.
Page 17 of 40
22. Grant Title: “A Transdisciplinary Training Program for Public Health Researchers and Practitioners Wanting
To Impact Breast Cancer Disparities”
PI: Dr. Luisa Franzini; Agency: Susan J. Komen for the Cure Foundation;
Type: Training grant - KG090010; Period: 08/01/09-07/31/11; Total cost: $337,426; Effort: 5%.
Role: Co-Investigator and Mentor. 23. Grant Title: “A Transdisciplinary Training Program for Public Health Master and Doctoral Students Wanting
to Impact Breast Cancer Disparities”
PI: Dr. Luisa Franzini at UT-SPH; Agency: Susan J. Komen for the Cure Foundation;
Type: Training grant – KG111378; Period: 08/01/11-07/31/13; Total cost: $269,722; Effort: 5%.
Role: Co-Investigator and Mentor. 24. Bridge Funding from UT-SPH:
PI: Du, Xianglin L; Period: 04/01/10-06/30/10; Total cost: $8,097.00;
Description: This bridge funding is to cover 50% of a research associate’s 3-month salary for April 1-June 30,
2010. 25. Grant Title: “East Lancashire Stroke Prevention Project, England”
PI: JK Cruickshank; Agency: East Lancashire Health Authority, England:
Periods: 07/01/93-06/30/95; Total cost: $50,000. Effort: 40%.
Role: Co-investigator. 26. Grant Title: “Health Services Research in Under-Served Populations”
PI: J.L. Freeman; Agency: Agency for Healthcare Research and Quality (AHRQ);
Type: R24-HS11618; Period: 09/30/01-08/31/04; Effort: Core faculty/mentor with no salary support.
Role: Core Faculty and Mentor for post-doc fellows. 27. Grant Title: “NRSA Health of Older Minorities”
PI: J. S. Goodwin; Agency: NIH/NIA; Type: T32-AG00270; Period: 07/01/99-06/30/04.
Effort: Core faculty/mentor with no salary support.
Role: Core Faculty and Mentor for post-doc fellows. 28. Grant Title: “Training of Academic Surgical Oncologists”
PI: Dr. Lee Ellis at UT-MD Anderson Cancer Center; Agency: NIH/NCI;
Type and Grant Number: 5 T32-CA09599-19; Total cost: $525,198 per year;
Period: 2/1/07-1/31/08; Effort: Serving as mentor with no salary support.
Role: Mentor. 29. Grant Title: “Training of Academic Surgical Oncologists”
PI: Dr. Ellis, Lee at UT-MD Anderson Cancer Center; Agency: NIH/NCI;
Type and Grant Number: 2T32-CA009599-20; Total cost: $500,982 per year;
Period: 02/01/08-01/31/13; Effort: Serving as mentor with no salary support.
Role: Mentor. 30. Grant Title: “Behavioral Science Education Cancer Prevention/Control”
PI: Mullen, Patricia at UT-School of Public Health; Agency: NIH/NCI;
Type: 5R25-CA057712-15; Period: 09/01/07-08/31/08; Total cost: $480,910 per year;
Effort: Serving on advisory board and mentor with no salary support.
Role: Advisory Committee Member and Mentor. 31. Grant Title: “Behavioral Science Education Cancer Prevention/Control”
PI: Dr. Mullen, Patricia at UT-School of Public Health; Agency: NIH/NCI;
Type: 2R25-CA057712-16; Period: 09/01/08-08/31/13; Total cost: $480,910 per year;
C.V. for Xianglin Du, Ph.D.
Page 18 of 40
Effort: Serving on advisory board and mentor with no salary support.
Role: Advisory Board Member and Mentor. 32. Grant Title: “Research Training in Gasteroenterology”
PI: Dr. Hashem B. El-Serag at Baylor College of Medicine; Agency: NIH/NIDDK;
Type and Grant Number: T32DK083266-01; Total cost: $131,970 per year;
Period: 04/01/10 - 03/31/15; Effort: Serving as mentor with no salary support.
Role: Mentor. 33. Grant Title: “Effectiveness of Pegfilgrastim Vs. Filgrastim in Elderly Breast Cancer Patients”
PI: Rajan, Suja at UT-SPH; Agency: NIH/NCI; Type and Grant Number: R03-CA181977-01;
Period: 01/01/14 - 12/31/15 (NCE to 12/31/16); Total cost: $152,000; Effort: 5%;
Role: Co-Investigator. 34. Grant Title: “Repurposing Existing Drugs for Cancer Treatment using Electronic Health Records”
PI: Xu, Hua at UT-School of Biomedical Informatics; Agency: CPRIT;
Type and Grant Number: Recruitment of Rising Stars-CPRIT Scholar-R1307;
Period: 03/01/13 - 02/28/16; Total cost: $2,806,000; Effort: 5%;
Role: Co-Investigator.
PUBLICATIONS:
I. Articles Published in Peer-Reviewed Scientific Journals (in chronological order):
1. Du XL. The Status quo and reform of health centres. Journal of Chinese Rural Health Services Administration.
1984;3(4):17-19.
2. Du XL, Zu S, Zhu A. Assessment of activities of daily living in the elderly. Chinese Journal of Gerontology.
1988;8(3):163-166.
3. Du XL, Zhu A, Zu S. Active life expectancy in the elderly. Chinese Journal of Geriatrics. 1989;8(4):231-233.
4. Parker SG, Du XL, Bardsley MJ, Goodfellow J, Cooper RG, Cleary R, Broughton D, Striet C, James OFW. Measuring
outcomes in care of the elderly. Journal of the Royal College of Physicians of London. 1994;28:428-433.
5. Du XL, Cruickshank K, McNamee R, Saraee M, Sourbutts J, Summers A, Roberts N, Walton E, Holmes S. Case-
Control Study of Stroke and the Quality of Hypertension Control in North West England. BMJ. 1997;314:272-276.
6. Du XL, Sourbutts J, Cruickshank K, Summers A, Roberts N, Walton E, Holmes S. A community-based stroke register
in a high risk area for stroke in north west England. Journal of Epidemiology and Community Health. 1997;51:472-478.
7. Du XL, Freeman JL, Goodwin JS. The declining use of axillary dissection in patients with early stage breast cancer.
Breast Cancer Research and Treatment. 1999;53(2):137-144.
8. Du XL, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the advantages of
the linked Medicare and SEER data. Journal of Clinical Epidemiology. 1999;52(5):463-470.
9. Du XL, Freeman JL, Freeman DH, Syblik DA, Goodwin JS. Temporal and regional variation in the use of breast
conserving surgery and radiotherapy for older women with early stage breast cancer from 1983 to 1995. Journal of
Gerontology (Medical Sciences). 1999;54(9):474-478.
10. Du XL. Prevalence, treatment, control and awareness of high blood pressure and the risk of stroke in north west
England. Preventive Medicine. 2000;30(4):288-294.
C.V. for Xianglin Du, Ph.D.
Page 19 of 40
11. Du XL, McNamee R, Cruickshank K. Stroke risk from multiple risk factors combined with hypertension: a primary
care based case-control study in a defined population of northwest England. Annals of Epidemiology. 2000;10(6):380-
388.
12. Du XL, Freeman DH, Syblik DA. What drove changes in the use of breast conserving surgery for breast cancer since
the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement. Breast Cancer Research
and Treatment. 2000;62(1):71-79.
13. Du XL, Freeman JL, Warren JL, Nattinger AB, Zhang D, Goodwin JS. Accuracy and completeness of Medicare
claims data for surgical treatment of breast cancer. Medical Care. 2000;38(7):719-727.
14. Du XL, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: Findings from Medicare
claims data. Journal of Clinical Oncology. 2001;19(5):1455-1461.
15. Du XL, Goodwin JS. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer.
2001;92(4):730-737. PMCID: PMC2567284 (funded by NCI).
*16. Otiniano ME, Black SA, Ray LA, Du XL, Markides KS. Correlates of diabetic complications in Mexican American
elders. Ethnicity & Disease. 2002;12(2):252-258.
*17. Otiniano ME, Lorimor R, MacDonald E, Du XL. Common fraud experienced by the elderly: Findings from a 1998
survey in Houston, Texas. Texas Medicine. 2002;98(10):46-50.
18. Du XL, Freeman JL, Nattinger AB, Goodwin JS. Survival of women after breast conserving surgery for early stage
breast cancer. Breast Cancer Research and Treatment. 2002;72(1):23-31.
19. Du XL, Osborne C, Goodwin JS. Population-Based Assessment of Hospitalizations for Toxicity from Chemotherapy
in Older Women with Breast Cancer. Journal of Clinical Oncology. 2002;20(24):4636-4642. PMCID: PMC2566741
(funded by NCI).
20. Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between Consensus Recommendations and
Actual Community Use of Adjuvant Chemotherapy in Women with Breast Cancer. Annals of Internal Medicine.
2003;138(2):90-97. PMCID: PMC2566742 (funded by NCI).
*21. Otiniano ME, Du XL, Ottenbacher K, Black SA, Markides KS. Lower Extremity Amputations in Diabetic Mexican
American Elders: Incidence, Prevalence and Predictive Factors. Journal of Diabetes and Its Complications.
2003;17(2):59-65.
*22. Otiniano ME, Du XL, Ottenbacher K, Markides KS. The Effect of Diabetes Combined with Stroke on Disability,
Self-rated Health and Mortality in Older Mexican Americans: Results from the Hispanic EPESE. Archives of Physical
Medicine and Rehabilitation. 2003;84(5):725-730.
*23. Otiniano ME, Ottenbacher K, Markides KS, Ray LA, Du XL. Self-Reported Heart Attack in Mexican American
Elders: Examination of Incidence, Prevalence, and 7-year Mortality. Journal of the American Geriatrics Society.
2003;51(7):923-929.
*24. Otiniano ME, Markides KS, Ottenbacher K, Ray LA, Du XL. Self-Reported Diabetic Complications and 7-year
Mortality in Mexican American Elders: Findings from a Community-Based Study of Five Southwestern States. Journal of
Diabetes and Its Complications. 2003;17(5):243-248.
25. Du XL, Key CR, Osborne C. Community-Based Assessment of Adjuvant Hormone Therapy in Women with Breast
Cancer, 1991-1997. Breast Journal. 2004;10(5):433-439. PMCID: PMC2566743 (funded by NCI).
C.V. for Xianglin Du, Ph.D.
Page 20 of 40
*26. Otiniano ME, Du XL, Maldonado MR, Ray LA, Markides KS. Effect of metabolic syndrome on heart attack and
mortality in Mexican-American elderly persons: findings of 7-year follow-up from the Hispanic established population for
the epidemiological study of the elderly. Journal of Gerontology (Medical Sciences). 2005;60(4):466-70.
27. Osborne C, Ostir GV, Du XL, Peek MK, Goodwin JS. The influence of marital status on the stage at diagnosis,
treatment, and survival of older women with breast cancer. Breast Cancer Research and Treatment. 2005;93(1):41-7.
*28. Cormier JN, *Xing Y, Ding M, Lee J, Mansfield P, Gershenwald J, Ross M, Du XL. Population-Based Assessment
of Surgical Treatment Trends for Patients with Melanoma in the Era of Sentinel Lymph Node Biopsy. Journal of Clinical
Oncology. 2005;23(25):6054-6062.
29. Du XL, Jones DV, Zhang D. Effectiveness of Adjuvant Chemotherapy for Node-Positive Operable Breast Cancer in
Older Women. Journal of Gerontology (Medical Sciences). 2005;60(9):1137-1144. (A guest editorial was invited
specifically for this article). PMCID: PMC2567100 (funded by NCI).
30. Du XL, Chan W, Giordano S, Geraci JM, Delclos GL, Burau K, Fang S. Variation in Modes of Chemotherapy
Administration for Breast Carcinoma and Association with Hospitalization for Chemotherapy-related Toxicity. Cancer.
2005;104(5):913-924. PMCID: PMC2566845 (funded by NCI).
31. Du XL, Lairson DR, Begley CE, Fang S. Temporal and Geographic Variation in the Use of Hematopoietic Growth
Factors in Older Women Receiving Breast Cancer Chemotherapy: Findings from a Large Population-Based Cohort.
Journal of Clinical Oncology. 2005;23(34):8620-8628. PMCID: PMC2572993 (funded by NCI).
32. Du XL, Key CR, Dickie L, Darling R, Delclos GL, Waller K, Zhang D. Information on Chemotherapy and Hormone
Therapy from Tumor Registry Had Moderate Agreement with Chart Reviews. Journal of Clinical Epidemiology.
2006;59(1):53-60. PMCID: PMC2567281 (funded by NCI).
33. Du XL, Key CR, Dickie L, Darling R, Geraci JM, Zhang D. External Validation of Medicare Claims for Breast
Cancer Chemotherapy Compared with Medical Chart Reviews. Medical Care. 2006;44(2):124-131. PMCID:
PMC2567101 (funded by NCI).
34. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial Disparity and
Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage Prostate Carcinoma:
Findings From a Large Community-Based Cohort. Cancer. 2006;106(6):1276-1285.
35. Coker AL, Du XL, Fang S, Eggleston K. Socioeconomic Status and Cervical Cancer Survival among Older Women:
Findings from the SEER-Medicare Linked Data Cohorts. Gynecologic Oncology. 2006;102(2):278-284.
36. Sanderson M, Coker AL, Adriana P, Du XL, Peltz G, Fadden MK. A Multilevel Analysis of Socioeconomic Status
and Prostate Cancer Risk. Annals of Epidemiology. 2006;16(12):901-907.
37. Cormier JN, *Xing Y, Ding M, Lee J, Mansfield P, Gershenwald J, Ross M, Du XL. Ethnic Differences among
Patients with Cutaneous Melanoma. Archives of Internal Medicine. 2006;166(17):1907-1914.
38. Du XL, Gor BJ. Racial Disparities and Trends in Radiation Therapy After Breast-Conserving Surgery for Early-Stage
Breast Cancer in Women, 1992 to 2002. Ethnicity & Disease. 2007;17(1):122-128. PMCID: PMC2566852 (funded by
NCI).
*39. Berrios-Rivera JP, Fang S, Cabanillas ME, Cabanillas F, Lu H, Du XL. Variations in Chemotherapy and Radiation
Therapy in a Large Nationwide and Community-Based Cohort of Elderly Patients with Non-Hodgkin’s Lymphoma.
American Journal of Clinical Oncology. 2007;30(2):163-171.
40. Du XL, Meyer TE, Franzini L. Meta-Analysis of Racial Disparities in Survival in Association with Socioeconomic
Status among Men and Women with Colon Cancer. Cancer. 2007;109(11):2161-2170.
C.V. for Xianglin Du, Ph.D.
Page 21 of 40
*41. Rohatgi N, Du XL, Coker AL, Moye L, Wang M, Fang S. Chemotherapy and Survival for Patients with Multiple
Myeloma: Findings from a Large Nationwide and Population-Based Cohort. American Journal of Clinical Oncology.
2007;30(5):540-548.
*42. Holmes L, Chan W, Jiang Z, Du XL. Effectiveness of Androgen Deprivation Therapy in Prolonging Survival of
Older Men Treated for Locoregional Prostate Cancer. Prostate Cancer & Prostatic Diseases. 2007;10(4):388-95.
43. Du XL, Fang S, Vernon SW, El-Serag H, Shih YT, Davila J, Rasmus M. Racial Disparities and Socioeconomic Status
in Association with Survival in a Large Population-Based Cohort of Elderly Patients with Colon Cancer. Cancer.
2007;110(3):660-669.
*44. Cabanillas ME, Lu H, Fang S, Du XL. Elderly Patients with Non-Hodgkin’s Lymphoma Who Receive
Chemotherapy are at Higher Risk for Osteoporosis and Fractures. Leukemia & Lymphoma. 2007;48(8):1514-21.
45. Du XL, Fox EE, Lai D. Competing Causes of Death for Women with Breast Cancer and Change Over Time From
1975 to 2003. American Journal of Clinical Oncology. 2008;31(2):105-116. PMID: 18391593; PMCID: PMC2570158
(funded by NCI).
46. Du XL, Fang S, Meyer TE. Impact of Treatment and Socioeconomic Status on Racial Disparities in Survival among
Older Women with Breast Cancer. American Journal of Clinical Oncology. 2008;31(2):125-132. PMID: 18391595
(funded by AHRQ).
47. Du XL, Sun CC, Milam MR, Bodurka DC, Fang S. Ethnic Differences in Socioeconomic Status, Diagnosis, Treatment
and Survival Among Older Women with Epithelial Ovarian Cancer. International Journal of Gynecological Cancer.
2008;18(4):660-669. PMID: 17892451 (funded by AHRQ).
**48. Liu L, Coker AL, Du XL, Cormier JN, Ford CE, Fang S. Long-Term Survival after Radical Prostatectomy
Compared to Other Treatments in Older Men with Local or Regional Prostate Cancer. Journal of Surgical Oncology.
2008;97(7):583-591. PMID: 18381603 (funded by AHRQ).
49. Zhou Y, Wang H, Romaguera JE, Zhang Y, Fang W, Delasalle KB, Yi LK, Du XL, Wang M. Incidence Trends of
Mantle Cell Lymphoma in the United States between 1992 and 2004. Cancer. 2008:113(4):791-798. PMID: 18615506
(funded by AHRQ).
*50. Wang M, Burau KD, Fang S, Wang H, Du XL. Ethnic Variations in Diagnosis, Treatment, Socioeconomic Status
and Survival in Elderly Patients with Non-Hodgkin’s Lymphoma. Cancer. 2008;113(11):3231-3241. PMID: 18937267
(funded by AHRQ).
*51. White A, Liu CC, Xia R, Burau KD, Cormier JN, Chan W, Du XL. Racial Disparities and Treatment Trends in a
Large Cohort of Elderly African Americans and Caucasians with Colorectal Cancer, 1991 to 2002. Cancer.
2008;113(12):3400-3409. PMID: 18932248 (funded by AHRQ and NCI).
52. Coker AL, Eggleston KS, Du XL, Ramondetta L. Ethnic Disparities in Cervical Cancer Survival among Medicare
Eligible Women in a Multi-Ethnic Population. International Journal of Gynecological Cancer. 2009;19(1):13-20. PMID:
19258935 (funded by NCI).
*53. Hardy D, Liu CC, Xia R, Cormier JN, Chan W, White A, Burau KD, Du XL. Racial Disparities and Treatment
Trends in a Large Cohort of Elderly Black and White Patients with Non-Small Cell Lung Cancer. Cancer.
2009;115(10):2199-2211. PMID: 19365824 (funded by AHRQ).
*54. Taylor LG, Canfield S, Du XL. Review of Major Adverse Effects of Androgen Deprivation Therapy in Men with
Prostate Cancer. Cancer. 2009;115(11):2388-2399. PMID: 19399748 (funded by AHRQ).
C.V. for Xianglin Du, Ph.D.
Page 22 of 40
*55. Bhargava A, Du XL. Racial and Socioeconomic Disparities in Adjuvant Chemotherapy for Node-Positive Operable
Breast Cancer in Older Women. Cancer. 2009;115(13):2999-3008. PMID: 19452539 (funded by AHRQ).
*56. Holmes L, Chan W, Jiang Z, Ward D, Essien EJ, Du XL. Impact of Androgen Deprivation Therapy on Racial/Ethnic
Disparities in Survival of Older Men Treated for Locoregional Prostate Cancer. Cancer Control. 2009;16(2):176-185.
PMID: 19337204; PMCID: PMC2664971 (funded by NCI).
*57. Badgwell B, Chang G, Rodriguez-Bigas M, Smith K, Lupo P, Frankowski F, Delclos G, Du XL, Cormier J.
Management and Outcomes of Anorectal Infection in the Cancer Patients. Annals of Surgical Oncology.
2009;16(10):2752-8. PMID: 19649556 (not funded by NIH).
58. Stuff JE, *LaCour M, Du XL, Franklin F, Liu Y, Hughes S, Peters R, Nicklas TA. The Prevalence of Food Insecurity
and Associated Factors among Households with Children in Head Start Programs in Houston, Texas and Birmingham,
Alabama. Race, Gender & Class. 2009;16:31-47. (not funded by NIH).
*59. Nurgalieva Z, Liu CC, Du XL. Risk of Hospitalizations Associated with Adverse-Effects of Chemotherapy in a
Large Community-based Cohort of Elderly Women with Ovarian Cancer. International Journal of Gynecological Cancer.
2009;19(8):1314-21. PMID: 19417586 (funded by AHRQ).
*60. Hardy D, Xia R, Liu CC, Cormier JN, Nurgalieva Z, Du XL. Racial Disparities and Survival for Non-Small Cell
Lung Cancer in a Large Cohort of Black and White Elderly Patients. Cancer. 2009;115(20):4807-4818. PMID: 19626650
(funded by AHRQ).
61. Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Chan W, Hardy D, Burau KD. Cardiac Toxicity Associated with
Anthracycline-Containing Chemotherapy in Older Women with Breast Cancer. Cancer. 2009;115(22):5296-5308.
[Erratum in: Cancer. 2009;115:5849-51]. PMID: 19672997 (funded by AHRQ).
62. Du XL, Xia R, Hardy D. Relationship between Chemotherapy Use and Cognitive Impairments in Older Women with
Breast Cancer: Findings from a Large Population-Based Cohort. American Journal of Clinical Oncology. 2010;33(6):533-
43. PMID: 20023570 (funded by AHRQ).
*63. Nurgalieva Z, Xia R, Liu CC, Burau KD, Hardy D, Du XL. Risk of Chemotherapy-induced Peripheral Neuropathy in
Large Population-based Cohorts of Elderly Patients with Breast, Ovarian and Lung Cancer. American Journal of
Therapeutics. 2010;17(2):148-158. PMID: 19417586 (funded by AHRQ).
*64. Hardy D, Cormier JN, Xing Y, Liu CC, Xia R, Du XL. Chemotherapy-Associated Toxicity in a Large Cohort of
Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2010;5(1):90-98. PMID: 19884853 (funded by
AHRQ).
*65. Guadagnolo BA, Liu CC, Cormier JN, Du XL. Evaluation of Trends in the Use of Intensity Modulated Radiation
Therapy for Head and Neck Cancer from 2000 through 2005: Socioeconomic Disparity and Geographic Variation in a
Large Population based Cohort. Cancer. 2010;116(14):3505-12. PMID: 20564123 (funded by AHRQ).
66. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Utilization of Screening for
Hepatocellular Carcinoma in the United States. Hepatology. 2010;52(1):132-41. PMID: 20578139; PMCID:
PMC3835698 (funded by American Cancer Society and NIH).
67. Du XL, Liu CC. Racial/Ethnic Disparities in Socioeconomic Status, Diagnosis, Treatment and Survival among
Medicare-insured Men and Women with Head and Neck Cancer. Journal of Health Care for the Poor and Underserved.
2010;21(3):913-930. PMID: 20693735 (funded by AHRQ).
C.V. for Xianglin Du, Ph.D.
Page 23 of 40
*68. White A, Vernon SW, Franzini L, Du XL. Disparities in Colorectal Cancer Survival: To What Extent Are Racial
Disparities Explained by Differences in Treatment, Tumor or Hospital Characteristics? Cancer. 2010;116(19):4622-31.
PMID: 20626015; PMCID: PMC2946464 (funded by NCI).
*69. Hardy D, Liu CC, Cormier JN, Xia R, Du XL. Cardiac Toxicity in Association with Chemotherapy and Radiation
Therapy in a Large Cohort of Older Patients with Non-Small Cell Lung Cancer. Annals of Oncology. 2010;21(9):1825-
33. PMID: 20211871; PMCID: PMC2980940 (funded by AHRQ).
***70. Lin YF, Lairson DR, Chan W, Du XL, Leung KS, Kennedy-Nasser AA, Gottschalk AM, Bollard CM, Brenner
MK, Krance RA. The Costs and Cost-Effectiveness of Allogeneic Peripheral Blood Stem Cell Transplantation versus
Bone Marrow Transplantation in Pediatric Patients with Acute Leukemia. Biology of Blood and Marrow Transplantation.
2010;16:1272-81. PMID: 20348004; PMCID: PMC2919628 (funded by NIH).
*71. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Comparative Effectiveness of White Blood Cell Growth
Factors on Neutropenia, Infection, and Survival in Older People with Non-Hodgkin's Lymphoma Treated with
Chemotherapy. Journal of the American Geriatrics Society. 2010;58(10):1885-95. PMID: 20840455 (funded by AHRQ).
*72. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Use of white blood cell growth factors and risk of acute
myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.
Cancer. 2010;116(22):5279-89. PMID: 20665502 (funded by AHRQ).
*73. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Cost-effectiveness of white blood cell growth factor use
among a large nationwide cohort of elderly non-Hodgkin’s lymphoma patients treated with chemotherapy. Value in
Health. 2011;14(2):253-262. PMID: 21402294 (funded by AHRQ).
***74. Lin YF, Lairson DR, Chan W, Du XL, Heslop HE, Brenner MK, Krance RA. Children with Acute Leukemia: A
Comparison of Outcomes from Allogeneic Blood Stem Cell and Bone Marrow Transplantation. Pediatric Blood and
Cancer. 2011;56(1):143-51. PMID: 21108446 (not funded by NIH).
*75. Liu CC, Xia R, Guadagnolo A, Cormier JN, Du XL. Risk of Xerostomia in Association with the Receipt of
Radiation Therapy in Older Patients with Head and Neck Cancer. American Journal of Therapeutics. 2011;18(3):206-215.
PMID: 20068441 (funded by AHRQ).
*76. Nurgalieva Z, Liu CC, Du XL. Chemotherapy Use and Risk of Bone Marrow Suppression in a Large Population-
Based Cohort of Older Women with Breast and Ovarian Cancer. Medical Oncology. 2011;28(3):716-25. PMID:
20361359 (funded by AHRQ).
*77. Hu CY, Delclos GL, Chan W, Du XL. Assessing the Initiation and Completion of Adjuvant Chemotherapy in a
Large Nationwide and Population-Based Cohort of Elderly Patients with Stage III Colon Cancer. Medical Oncology.
2011;28(4):1062-1074. PMID: 20714945 (funded by AHRQ).
*78. Hu CY, Delclos GL, Chan W, Du XL. Post-Treatment Surveillance in a Large Cohort of Colon Cancer Patients.
American Journal of Managed Care. 2011;17:329-336. PMID: 21718080 (funded by AHRQ).
*79. Cheng L, Eng C, DeJesus Y, Nieman LZ, Kapadia AS, Du XL. Trends in Colorectal Cancer Incidence by Anatomic
Site and Disease Stage in the United States from 1976 to 2005. American Journal of Clinical Oncology. 2011;34(6):573-
80. PMID: 21217399 (funded by AHRQ).
*80. White A, Coker AL, Du XL, Eggleston KS, Williams M. Racial/ethnic disparities in survival among men diagnosed
with prostate cancer in Texas. Cancer. 2011;117(5):1080-1088. PMID: 21351084; PMCID: PMC3100436 (funded by
NIH).
C.V. for Xianglin Du, Ph.D.
Page 24 of 40
***81. Hosain MGM, Sanderson M, Du XL, Chan W, Strom S. Racial/ethnic differences in predictors of PSA screening
in a tri-ethnic population. Central European Journal of Public Health. 2011;19:30-34. PMID: 21526653 (not funded by
NIH).
*82. Hardy D, Chan W, Liu CC, Cormier JN, Xia R, Bruera E, Du XL. Racial disparities in the use of hospice services
according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer.
2011;117 (7):1506-1515. PMID: 21425152 (funded by AHRQ).
83. *Clague JN, Reynolds P, Sullivan-Halley J, Ma H, Lacey JV, Henderson KD, Ursin G, West DW, Chang S, Delclos
G, Du XL, Forman MR, Bernstein L. Menopausal Hormone Therapy Does not Influence Lung Cancer Risk: Results from
the California Teachers Study. Cancer Epidemiology, Biomarkers & Prevention. 2011;20(3):560-4. PMID: 21266521;
PMCID: PMC3065239 (funded by NCI).
*84. White A, Vernon SW, Franzini L, Du XL. Racial and Ethnic Disparities in Colorectal Cancer Screening Persisted
Despite Expansion of Medicare's Screening Reimbursement. Cancer Epidemiology, Biomarkers & Prevention.
2011;20(5):811-817. PMID: 21546366 (funded by NCI).
85. Du XL, Xia R, Burau K, Liu CC. Cardiac Risk Associated with the Receipt of Anthracycline and Trastuzumab in a
Large Nationwide Cohort of Older Women with Breast Cancer, 1998-2005. Medical Oncology. 2011;28(supplement
1):S80-90. PMID: 20967512 (funded by AHRQ).
86. Du XL, Lin CC, Johnson NJ, Altekruse S. Effects of Individual-Level Socioeconomic Factors on Racial Disparities in
Cancer Treatment and Survival: Findings from the National Longitudinal Mortality Study, 1979-2003. Cancer.
2011;117(14):3242-51. PMID: 21264829; PMCID: PMC3090714 (funded by NCI and Census Burau).
*87. Hardy D, Chan W, Liu CC, Cormier JN, Xia R, Bruera E, Du XL. Racial disparities and length-of-stay in hospice in
an elderly cohort with non-small cell lung cancer. Palliative Medicine. 2012;26(1):61-71. PMID: 21606129 (funded by
AHRQ).
**88. Sail K, Franzini L, Lairson DR, Du XL. Differences in Treatment and Survival among African American and
Caucasian Women with Early Stage Operable Breast Cancer. Ethnicity and Health. 2012;17(3):309-323. PMID:
22066691 (funded by AHRQ and Susan Komen for the Cure).
***89. Sail K, Franzini L, Lairson DR, Du XL. Clinical and Economic Outcomes Associated With Adjuvant
Chemotherapy In Elderly Patients With Early Stage Operable Breast Cancer. Value in Health. 2012;15(1):72-80. PMID:
22264974 (funded by Susan Komen for the Cure Foundation).
*90. Abotchie PN, Vernon SW, Du XL. Gender differences in colorectal cancer incidence in the United States, 1975-
2006. Journal of Women’s Health. 2012;21(4):393-400. PMID: 22149014; PMCID: PMC3321677 (funded by NCI).
*91. Hu CY, Chan W, Delclos G, Du XL. Adjuvant Chemotherapy and Risk of Gastrointestinal, Hematological and
Cardiac Toxicities for Stage III Colon Cancer among Elderly Patients. American Journal of Clinical Oncology.
2012;35(3):228-236. PMID: 21383605 (funded by AHRQ).
92. Wang H, Chen Y, Li F, Delasalle K, Wang J, Alexanian A, Kwak L, Rustveld L, Du XL, Wang M. Temporal and
Geographic Variations of Waldenström’s Macroglobulinemia Incidence: A Large Population-Based Study. Cancer.
2012;118(15):3793-3800. PMID: 22139816 (not funded by NIH).
***93. Hosain MGM, Sanderson M, Du XL, Chan W, Strom S. Racial/ethnic differences in treatment discussed, chosen
and received for prostate cancer in a tri-ethnic population. American Journal of Men's Health. 2012;6(03):249-257.
PMID: 22419652; PMCID: PMC3368001 (funded by NIH).
C.V. for Xianglin Du, Ph.D.
Page 25 of 40
94. Cen P, Banki F, Cheng L, Khalil K, Du XL, Fallon MB, Amato R, Kaiser LR. Changes in Age, Stage distribution and
Survival of Patients with Esophageal Adenocarcinoma over Three Decades in the United States. Annals of Surgical
Oncology. 2012;19(5):1685-91. PMID: 22130619 (not funded by NIH).
*95. Cen P, Liu CC, Du XL. Comparison of Toxicity Profiles of Fluorouracil versus Oxaliplatin Regimens in a Large
Population-based Cohort of Older Patients with Colorectal Cancer. Annals of Oncology. 2012;23(6):1503-11. PMID:
22021820 (funded by AHRQ).
***96. Kowalkowski MA, Hart SL, Du XL, Baraniuk S, Latini DM. Cancer Perceptions: Implications from the 2007
Health Information National Trends Survey. Journal of Cancer Survivorship. 2012;6(3):287-95. PMID: 22457218 (not
funded by NIH).
***97. Wendt JK, Symanski E, Du XL. Estimation of Asthma Incidence Among Low-Income Children in Texas: A
Novel Approach Using Medicaid Claims Data. American Journal of Epidemiology. 2012;176(8):744-50. PMID:
23024134; PMCID: PMC3571251 (funded by NIH/NIOSH).
***98. Panchal J, Lairson D, Chan W, Du XL. Geographic Variation and Socio-demographic Disparity in the Utilization
of Oxaliplatin-containing Chemotherapy in Patients with Stage-III Colon Cancer. Clinical Colorectal Cancer.
2013;12(2):113-121. PMID: 23137529 (funded by AHRQ and CPRIT).
*99. Li N, Du XL, Reitzel L, Xu L, Sturgis E. Impact of enhanced detection on the increase in thyroid cancer incidence in
the US: review of incidence trends by socioeconomic status within the Surveillance, Epidemiology, and End Results
registry, 1980-2008. Thyroid. 2013;23(1):103-110. PMID: 23043274; PMCID: PMC3539256 (funded by NIH).
*100. Liu L, Wang H, Chen Y, Liu G, Rustveld L, Du XL. Splenic Marginal Zone Lymphoma: a population-based study
on the incidence and survival in the United States from 2001 to 2008. Leukemia and Lymphoma. 2013;54(7):1380-86.
PMID: 23101590 (not funded by NIH).
*101. Nurgalieva Z, Franzini L, Morgan R, Vernon SW, Liu CC, Du XL. Impact of timing of adjuvant chemotherapy
initiation and completion after surgery on racial disparities in survival among women with breast cancer. Medical
Oncology. 2013;30:419 (pages 1-9). PMID: 23292872 (funded by AHRQ and Komen for the Cure foundation).
***102. Wang GD, Lai DJ, Burau KD, Du XL. Potential gains in life expectancy from reducing heart disease, cancer,
Alzheimer’s disease, kidney disease or HIV/AIDS as major causes of death in the USA. Public Health. 2013;127(4):348-
356. PMID: 23507421 (not funded by NIH).
***103. Cai Y, Lai D, Waller K, Du XL, Burau K, Symanski E. Statistical Analysis of the Day of the Week Effect on
Births in Harris County, Texas. Journal of Biological Systems. 2013;21(2):1350014 (pages 1-8). (not funded by NIH).
104. Du XL, Parikh RC, Lairson DR, Giordano SH, Cen P. Comparative Effectiveness of Platinum-based Chemotherapy
versus Taxane and Other Regimens for Ovarian Cancer. Medical Oncology. 2013;30(1):440 (pages 1-14). PMID:
23307252 (funded by AHRQ & CPRIT).
105. Du XL, Cai Y, Symanski E. Association between Chemotherapy and Cognitive Impairments in a Large Cohort of
Patients with Colorectal Cancer. International Journal of Oncology. 2013;42(6):2123-2133. PMID: 23563930 (funded by
AHRQ & CPRIT).
106. Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X.
Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival
among Asian Americans with colorectal cancer. British Journal of Cancer. 2013;108:1508-1514. PMID: 23470470;
PMCID: PMC3629437 (funded by NIH).
C.V. for Xianglin Du, Ph.D.
Page 26 of 40
*107. Nurgalieva Z, Franzini L, Morgan R, Vernon SW, Du XL. Utilization of lymph node dissection, race/ethnicity and
breast cancer outcomes. American Journal of Managed Care. 2013;19(10):805-810. PMID: 24304159 (funded by AHRQ
and Susan Komen for the Cure).
108. Liu P , Li X, Mittendorf EA, Li J, Du XL, He J, Ren Y, Yang J, Hunt KK, Yi M. Comparison of clinicopathologic
features, and survival in young American women aged 18-39 years in different ethnic groups with breast cancer. British
Journal of Cancer. 2013;109(5):1302-9. PMID: 23907433; PMCID: PMC3778276 (funded by NIH).
*109. Nurgalieva Z, Franzini L, Morgan R, Vernon SW, Du XL. Surveillance mammography use after treatment of
primary breast cancer and racial disparities in survival. Medical Oncology. 2013;30(4):691 (pages 1-8). PMID: 23975632
(funded by AHRQ, Susan Komen for the Cure, and CPRIT).
***110. Tran DT, Gay I, Du XL, Fu Y, Bebermeyer RD, Newmann A, Streckfus C, Chan W, Walji M. Assessing
Periodontitis in Populations: A Systematic Review of the Validity of Partial Mouth Examination Protocols. Journal of
Clinical Periodontology. 2013;40(12):1064-71. PMID: 24192071; PMCID: PMC3859863 (funded by NIH).
***111. Tran DT, Gay I, Du XL, Fu Y, Bebermeyer RD, Newmann A, Streckfus C, Chan W, Walji M. Assessment of
Partial-Mouth Periodontal Examination Protocols for Periodontitis Surveillance. Journal of Clinical Periodontology.
2014;41(9):846-52. PMID: 25041094; PMCID: PMC4318801 (funded by NIH).
***112. Huo J, Lairson DR, Du XL, Chan W, Buchholz TA, Guadagnolo BA. Survival and cost-effectiveness of hospice
care for metastatic melanoma patients. American Journal of Managed Care. 2014;20(5):366-373. PMID: 25181566 (not
funded by NIH).
113. Lairson DR, Parikh RC, Cormier JN, Du XL. Cost-utility analysis of platinum-based chemotherapy versus taxane
and other regimens for ovarian cancer. Value in Health. 2014;17(1):34-42. PMID: 24438715 (funded by AHRQ).
*114. Tong L, Ahn C, Symanski E, Lai D, Du XL. Temporal trends in the leading causes of death among a large national
cohort of patients with colorectal cancer from 1975 to 2009 in the United States. Annals of Epidemiology.
2014;24(6):411-417. PMID: 24529646 (funded by AHRQ).
*115. Tong L, Ahn C, Symanski E, Lai D, Du XL. Effects of newly developed chemotherapy regimens, comorbidities,
chemotherapy-related toxicity on the changing patterns of the leading causes of death in elderly patients with colorectal
cancer. Annals of Oncology. 2014;25(6):1234-42. PMID: 24681607; PMCID: PMC4110447 (funded by AHRQ).
*116. Tong L, Ahn C, Symanski E, Lai D, Du XL. Relative impact of earlier diagnosis and improved treatment on
survival for colorectal cancer: A US database study among elderly patients. Cancer Epidemiology. 2014;38(6):733-740.
PMID: 25454261 (funded by AHRQ and CPRIT).
***117. Wendt JK, Symanski E, Stock TH, Chan W, Du XL. Association of Short-Term Increases in Ambient Air
Pollution and Timing of Initial Asthma Diagnosis among Medicaid-Enrolled Children in a Metropolitan Area.
Environmental Research. 2014;131:50-58. PMID: 24657516; PMCID: PMC4502952 (funded by NIH/NIOSH).
*118. Sheth R, Flescher-Peskin M, Du XL. Duration of Hepatitis B Vaccine Immunity in Pediatric Dialysis Patients.
Pediatric Nephrology. 2014;29(10):2029-37. PMID: 24839216 (not funded by NIH).
119. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Chemotherapy Regimens in Elderly
Patients with Stage III Colon Cancer. PharmacoEconomics. 2014;32(10):1005-13. PMID: 24920195 (funded by AHRQ
and CPRIT).
***120. Kowalkowski MA, Mims MA, Day RS, Du XL, Chan W, Chiao EY. Longer duration of combination
antiretroviral therapy reduces the risk of Hodgkin lymphoma: A cohort study of HIV-infected male veterans. Cancer
Epidemiology. 2014;38(4):386-92. PMID: 24947588; PMCID: PMC4447432 (funded by NIH).
C.V. for Xianglin Du, Ph.D.
Page 27 of 40
***121. Kowalkowski MA, Day RS, Du XL, Chan W, Chiao E. Cumulative HIV viremia and non-AIDS-defining
malignancies among a sample of HIV-infected male veterans. Journal of Acquired Immune Deficiency Syndromes.
2014;67(2):204-11. PMID: 25078536; PMCID: PMC4162758 (funded by NIH).
*122. Clague J, Reynolds P, Henderson KD, Sullivan-Halley J, Ma H, Lacey JV Jr, Chang S, Delclos GL, Du XL,
Forman MR, Bernstein L. Menopausal Hormone Therapy and Lung Cancer-Specific Mortality Following Diagnosis: The
California Teachers Study. PLoS One. 2014;9(7):e103735. PMID: 25079077; PMCID: PMC4117568 (funded by NIH).
*123. Zhang Y, Fu S, Du XL. Increasing Utilization and Predictors of Hematopoietic Growth Factors in Patients
Diagnosed with Colorectal Cancer: Findings From a Large National Population-based Cohort in the United States, 1992-
2009. Medical Oncology. 2014;31(10):242 (pages 1-11). PMID: 25231751 (funded by AHRQ and CPRIT).
***124. Russell HV, Okcu MF, Kamdar K, Shah MD, Kim E, Swint JM, Chan W, Du XL, Franzini L, Ho V. Algorithm
for analysis of administrative pediatric cancer hospitalization data according to indication for admission. BMC Medical
Informatics and Decision Making. 2014;14(1):88. PMID: 25274165; PMCID: PMC4197316 (funded by CPRIT training
grant).
125. Ren Y, Black DM, Mittendorf EA, Liu P, Li X, Du XL, He J, Yang J, Hunt KK, Yi M. Crossover Effects of
Estrogen Receptor Status on Breast Cancer-Specific Hazard Rates by Age and Race. PLoS One. 2014 Oct
21;9(10):e110281. PMID: 25333877; PMCID: PMC4204865 (funded by NIH).
***126. Kadakia A, Rajan SS, Abughosh S, Du XL, Johnson ML. CMF-regimen preferred as first-course chemotherapy
for older and sicker women with breast cancer: Findings from a SEER-Medicare based population study. American
Journal of Clinical Oncology. 2015;38(2):165-173. PMID: 23608830 (not funded by NIH).
***127. Huo J, Du XL, Lairson DR, Chan WY, Jiang J, Buchholz TA, Guadagnolo BA. Utilization of Surgery,
Chemotherapy, Radiation Therapy, and Hospice at the End of Life for Patients Diagnosed with Metastatic Melanoma.
American Journal of Clinical Oncology. 2015;38(3):235-41. PMID: 23648436; PMCID: PMC3796177 (funded by NIH).
*128. Liu Z, Zhang Y, Franzini L, Cormier JN, Chan W, Xu H, Du XL. Trends and Variations in Breast and Colorectal
Cancer Incidence from 1995 to 2011: A Comparative Study between the Texas Cancer Registry and National Cancer
Institute’s Surveillance, Epidemiology and End Results Data. International Journal of Oncology. 2015;46(4):1819-1826.
PMID: 25672365; PMCID: PMC4356494 (funded by CPRIT).
129. Du XL, Zhang Y, Parikh RC, Lairson DR, Cai Y. Comparative Effectiveness of Chemotherapy Regimens in
Prolonging Survival for Two Large Population-based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-
2009. Journal of the American Geriatrics Society. 2015;63(8):1570-82. PMID: 26200214 (funded by AHRQ & CPRIT).
*130. Poonawalla IB, Lairson DR, Chan W, Piller LB, Du XL. Cost-Effectiveness of Neoadjuvant Chemotherapy versus
Primary Surgery in Elderly Patients with Advanced Ovarian Cancer. Value in Health. 2015;18(4):387-395. PMID:
26091592 (funded by AHRQ).
*131. Ludwig MS, Kuban DA, Du XL, Lopez DS, Yamal JM, Strom SS. The Role of Androgen Deprivation Therapy on
Biochemical Failure and Distant Metastasis in Intermediate-Risk Prostate Cancer: A Retrospective Study of the Effects of
Radiation Dose Escalation. BMC Cancer. 2015;15(1):190. PMID: 25885406; PMCID: PMC4472156 (funded by NIH).
*132. Wang X, Du XL. Socio-demographic and Geographic Variations in the Utilization of Hormone Therapy in Older
Women with Breast Cancer after Medicare Part-D Coverage. Medical Oncology. 2015;32(5):154 (pages 1-14). PMID:
25837434 (funded by AHRQ and CPRIT).
133. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Treatments for Advanced Non-Small
Cell Lung Cancer. American Journal of Pharmacy Benefits. 2015;7(6):271-279. (funded by AHRQ and CPRIT).
C.V. for Xianglin Du, Ph.D.
Page 28 of 40
*134. Zhang Y, Franzini L, Chan W, Xu H, Du XL. Effects of Health Insurance on Tumor Stage, Treatment, and Survival
in Large Cohorts of Patients with Breast and Colorectal Cancer. Journal of Health Care for the Poor and Underserved.
2015;26(4):1336-58. PMID: 26548682 (funded by CPRIT).
*135. Poonawalla IB, Parikh RC, Du XL, VonVille HM, Lairson DR. Cost-Effectiveness of Chemotherapeutic Agents
and Targeted Biologics in Ovarian Cancer: A Systematic Review. PharmacoEconomics. 2015;33(11):1155-85. (Invited
systematic review). PMID: 26072142 (funded by AHRQ).
136. Du XL, Zhang Y. Risks of Venous Thromboembolism, Stroke, Heart Disease and Myelodysplastic Syndrome
Associated with Hematopoietic Growth Factors in a Large Population-based Cohort of Patients with Colorectal Cancer.
Clinical Colorectal Cancer. 2015;14(4):e21-31. PMID: 26119923 (funded by AHRQ and CPRIT).
137. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Effectiveness of Chemotherapy for Breast Cancer and
Age Effect in Older Women. Value in Health. 2015;18(8):1070-78. PMID: 26686793 (funded by AHRQ and CPRIT).
***138. Park M, Lai D, Du XL, Delclos GP, Moye LA. General Linear Models in a Missing Outcome Environment of
Clinical Trials Incorporating with Splines for Time-Invariant Continuous Adjustment. American Journal of Biostatistics.
2015;5(1):7-51. DOI: 10.3844/amjbsp.2015.7.51. (not funded by NIH).
139. Du XL, Parikh RC, Lairson DR. Racial and Geographic Disparities in the Patterns of Care and Costs at the End of
Life for Patients with Lung Cancer in 2007-2010 after the 2006 Introduction of Bevacizumab. Lung Cancer.
2015;90(3):442-250. PMID: 26439736 (funded by AHRQ and CPRIT).
140. Du XL, Zhang Y, Hardy D. Temporal and Geographic Variations in the Receipt of Colony-Stimulating Factors and
Erythropoiesis-Stimulating Agents in a Large Retrospective Cohort of Older Women with Breast Cancer from 2000 to
2009. American Journal of Therapeutics. 2016;23(2):e411-e421. PMID: 25756469 (funded by AHRQ and CPRIT).
*141. Poonawalla IB, Piller LB, Lairson DR, Chan W, Du XL. Impact of Hematopoietic Growth Factors on Blood
Transfusion Needs, Incidence of Neutropenia and Overall Survival among Elderly Advanced Ovarian Cancer Patients
Treated With Chemotherapy. International Journal of Gynecological Cancer. 2016;26(1):95-103. PMID: 26509851
(funded by AHRQ).
***142. Parikh RC, Du XL, Morgan RO, Lairson DR. Patterns of Treatment Sequences in Chemotherapy and Targeted
Biologics for Metastatic Colorectal Cancer: Findings from a Large Community-based Cohort of Elderly Patients. Drugs
Real World Outcomes. 2016;3(1):69-82. PMID: 27073759; PMCID: PMC4819481 (funded by AHRQ and CPRIT).
**143. Panchal J, Lairson D, Chan W, Du XL. Geographic Variation in Oxaliplatin-Chemotherapy and Survival in Colon
Cancer Patients. American Journal of Therapeutics. 2016;23(3):e720-9. PMID: 24368611 (funded by AHRQ).
***144. Huo J, Lairson DR, Du XL, Chan W, Jiang J, Buchholz TA, Guadagnolo BA. Hospital Case Volume is
Associated With Improved Survival for Patients With Metastatic Melanoma. American Journal of Clinical Oncology.
2016;39(5):491-496. PMID: 24755661 (not funded by NIH).
*145. Farias AJ, Du XL. Ethnic differences in initiation and timing of adjuvant endocrine therapy among older women
with hormone receptor-positive breast cancer enrolled in Medicare Part D. Medical Oncology. 2016;33(2):19 (pages 1-
14). PMID: 26786154; PMCID: PMC4934890 (funded by NCI, AHRQ and CPRIT).
***146. Tran DT, Gay I, Du XL, Fu Y, Bebermeyer RD, Newmann A, Streckfus C, Chan W, Walji M. Partial-mouth
periodontal examination protocol for estimating periodontitis extent and severity in a United States population. Clinical
and Experimental Dental Research. 2016;2(1):73-79. DOI: 10.1002/cre2.24. (not funded by NIH).
147. Du XL, Zhang Y, Hardy D. Associations between Hematopoietic Growth Factors and Risks of Venous
Thromboembolism, Stroke, Heart Disease and Myelodysplastic Syndrome: Findings from a Large Population-based
C.V. for Xianglin Du, Ph.D.
Page 29 of 40
Cohort of Women with Breast Cancer. Cancer Causes and Control. 2016;27(5):695-707. PMID: 27059219 (funded by
AHRQ and CPRIT).
*148. Liu Z, Zhang K, Du XL. Risks of Developing Breast and Colorectal Cancer in Association with Incomes and
Geographic Locations in Texas: a Retrospective Cohort Study. BMC Cancer. 2016;16(1):294. doi: 10.1186/s12885-016-
2324-z.. PMID: 27118258; PMCID: PMC4847204 (funded by CPRIT and AHRQ).
149. Li D, Du XL, Ren Y, Liu P, Li S, Yang J, Lv M, Chen L, Wang X, Li E, Yang J, Yi M. Comparative Analysis of
Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer. PLoS One. 2016
May 31;11(5):e0156617. PMID: 27244238; PMCID: PMC4886968 (not funded by NIH).
*150. Poonawalla IB, Piller LB, Lairson DR, Chan W, Du XL. Use of Hematopoietic Growth Factors and Risk of
Thromboembolic and Pulmonary Toxicities in Elderly Patients with Advanced Ovarian Cancer. Women's Health Issues.
2016;26(5):574-583. PMID: 27365286 (funded by AHRQ).
151. Yang J, Du XL, Li ST, Wang BY, Wu YY, Chen ZL, Lv M, Shen YW, Wang X, Dong DF, Li D, Wang F, Li EX, Yi
M, Yang J. Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A
Population-Based Study of 57,847 Patients. PLoS One. 2016 Dec 9;11(12):e0167540. PMID: 27936129; PMCID:
PMC5144913 (not funded by NIH).
*152. Ludwig MS, Kuban DA, Strom SS, Du XL, Lopez DS, Yamal JM. Assessing the Optimum use of Androgen-
Deprivation Therapy in High Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy. American
Journal of Men's Health. 2017;11(1):73–81. PMID: 25891393 (not funded by NIH).
*153. Rajan SS, Cai Y, Yi M, Tsai CL, Du XL. Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients
Receiving Chemotherapy: A SEER-Medicare Based Study. American Journal of Clinical Oncology. 2017;40(1):66-74.
PMID: 25068470 (funded by AHRQ).
***154. Parikh RC, Du XL, Morgan RO, Lairson DR. Cost Effectiveness of Treatment Sequences of Chemotherapies and
Targeted Biologics for Elderly Metastatic Colorectal Cancer Patients. Journal of Managed Care and Specialty Pharmacy.
2017 Jan;23(1):64-73. PMID: 28025930 (funded by AHRQ and CPRIT).
*155. Farias AJ, Du XL. The association between out-of-pocket costs, race/ethnicity, and adjuvant endocrine therapy
adherence among Medicare patients with breast cancer. Journal of Clinical Oncology. 2017 Jan;35(1):86-95. PMID:
28034069; PMCID: PMC5455689 (funded by NCI, AHRQ and CPRIT).
156. Zhu P, Du XL, Lu G, Zhu JJ. Survival Benefit of Glioblastoma Patients after FDA Approval of Temozolomide
Concomitant with Radiation and Bevacizumab: A Population-Based Study. Oncotarget. 2017 Jul 4;8(27):44015-44031.
doi: 10.18632/oncotarget.17054. PMID: 28467795 (not funded by NIH).
157. Chen Z, Ren Y, Du XL, Yang J, Shen Y, Li S, Wu Y, Lv M, Dong D, Li E, Li W, Liu PJ, Yang J, Yi M. Incidence
and Survival Differences in Esophageal Cancer among Ethnic Groups in the United States. Oncotarget. 2017 Jul
18;8(29):47037-47051. doi: 10.18632/oncotarget.16694. PMID: 28410201 (not funded by NIH).
*158. Chen Y, Lairson DR, Chan W, Huo J, Du XL. Cost-effectiveness of novel agents in multiple myeloma from a US
payer’s perspective. Journal of Managed Care and Specialty Pharmacy. 2017 Aug;23(8):831-843. PMID: 28737990
(funded by AHRQ and CPRIT).
*159. Farias AJ, Du XL. Racial differences in adjuvant endocrine therapy use and discontinuation in association with
mortality among Medicare breast cancer patients by receptor status. Cancer Epidemiology, Biomarkers and Prevention.
2017 Aug;26(8):1266-75. PMID: 28515111; PMCID: PMC5540737 (funded by NCI, AHRQ and CPRIT).
C.V. for Xianglin Du, Ph.D.
Page 30 of 40
*160. Chen Y, Lairson DR, Chan W, Du XL. Improved survival in Medicare patients with multiple myeloma: findings
from a large nationwide and population-based cohort. Medical Oncology. 2017 Sep;34(9):153. doi: 10.1007/s12032-017-
1001-7. PMID: 28776319 (funded by AHRQ and CPRIT).
*161. Fu S, Wang M, Lairson DR, Li R, Zhao B, Du XL. Trends and variations in mantle cell lymphoma incidence from
1995 to 2013: A comparative study between Texas and National SEER areas. Oncotarget. 2017;In press. PMID: (not
funded by NIH).
162. Zhao H, Zhang N, Ho V, Ding M, He W, Niu J, Yang M, Du XL, Zorzi D, Chavez-MacGregor M, Giordano SH.
Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 to
2011. Cancer. 2017;In press. PMID: (funded by CPRIT).
(Note: Of the 162 peer-reviewed articles, 158 were original articles and 4 (#40, 54, 110 & 135) were review articles.
*First author of the article was student or fellow or junior faculty whom I supervised/advised and I served as
corresponding author for the majority of these articles.
**First author of the article was student and I served on the committee and served as corresponding author.
***First author of the article was student and I served as the thesis/dissertation committee member.)
II. Research Letters, Editorial or Commentary Published in Scientific Journals or Professional Websites:
163. Du XL. Increase in the Use of Breast-Conserving Surgery. JAMA. 1999;282(4):326-327. PMID: PM10432025
(funded by NCI).
164. Du XL. Re: Trends in Use of Adjuvant Multi-Agent Chemotherapy and Tamoxifen for Breast Cancer in the
United States: 1975-1999. Journal of the National Cancer Institute. 2003;95:683-5. PMID: PM12734321 (funded
by NCI).
165. Du XL, Key CR. Chemotherapy in Women with Breast Cancer. Annals of Internal Medicine. 2003;139(10):868-
869. (funded by NCI).
166. Du XL. Enhance the FDA’s Postmarketing Drug Surveillance System of Adverse Effects through the Electronic
Healthcare Data. Epidemiology: Open Access. 2012;2(2):e104:1-3. doi:10.4172/2161-1165.1000e104. (Editorial)
(funded by AHRQ).
167. Du XL. Invited Commentary: “Socioeconomic Disparities in Diffuse Large B-Cell Lymphoma Outcomes”.
Expert Comment at http://www.practiceupdate.com/journalscan/9157. April 04, 2014.
168. Tong L, Du XL. Temporal trend in the diabetes-specific death rate among patients with colorectal cancer from
1975 to 2009 in the United States. Annals of Epidemiology. 2014;24(10):790. (Letter to the Editor) PMID:
25154036 (funded by AHRQ).
III. Abstracts Published in Scientific Journals or Professional Websites:
169. Du XL, Zhu A, Zu S. Multidimensional assessment of health care in the elderly. Proceedings of Postgraduate
Dissertations of Anhui Medical University. 1987;6:52-53.
170. Du XL. A five year retrospective study on cancer mortality in Anhui. Acta Anhui Medical University.
1987;22(1):4-5
171. Du XL, Zhu A, Zu S. Comprehensive evaluation of health status and functional well-being in the elderly. Acta
Anhui Medical University. 1988;23(2):146.
172. Du XL, Zhu A, Zu S. Comparative study on life expectancy and active life expectancy. Acta Anhui Medical
University. 1990;25(1):5.
173. Du XL, Bardsley M, Goodfellow J, Streit C, Cooper R, Broughton D, James OFW, Parker SG. Routine outcomes
assessment on a geriatric rehabilitation unit. Age & Ageing. 1992;21(suppl 2):7.
C.V. for Xianglin Du, Ph.D.
Page 31 of 40
174. Streit C, Parker SG, Du XL, Bardsley M, Goodfellow J, James OFW. Long term outcomes after admission to a
geriatric rehabilitation unit. Age & Ageing. 1993; 22(suppl 2):16-17.
175. Parker SG, Du XL, Goodfellow J, Broughton D, Cleary R, James OFW. Measuring outcomes assessment in
elderly patients in a geriatric day hospital. Age & Ageing. 1993;22(suppl 3):5.
176. Cruickshank JK, Du XL, Redmond P. Poorly managed hypertension in diabetes: the postural drop problem, and
potential for preventing premature stroke and coronary events. Diabetic Medicine. 1995;12 (suppl 2):S41.
177. Du XL, Cruickshank JK, Sourbutts J, Summers A, Roberts N, Walton E, Holmes S, Saraee M, Theodoulidis B.
Prevalence, treatment, control and awareness of high blood pressure among first-ever stroke patients in
Northwest England. Journal of Hypertension. 1996;14(suppl 1):S244.
178. Du XL, Cruickshank JK, McNamee R, Summers A. How far can stroke in routine general practice be prevented?
A case-control study in relation to quality of control of blood pressure in East Lancashire. Journal of
Epidemiology and Community Health. 1996;50:583.
179. Du XL, Cruickshank JK, McNamee R, Summers A. How closely is the risk of stroke related to quality of
hypertension detection and control? A case-control study in East Lancashire. Journal of Hypertension.
1996;14:1503-04.
180. Du XL, Cruickshank K, Sourbutts J, Summers A, Roberts N, Walton E and Holmes S. A population’s treatment,
control and awareness of hypertension in relation to stroke risk in northwest England. Annals of Epidemiology.
1998;8:469.
181. Du XL, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the
advantages of the linked Medicare and SEER data. Annals Epidemiology. 1998;8:469.
182. Du XL, McNamee R, Cruickshank K. Stroke risk from multiple risk factors combined with hypertension: a
primary care based case-control study in a defined population of northwest England. American Journal of
Epidemiology. 2000;151(suppl):S36.
183. Du XL, Freeman JL, Nattinger AB, Goodwin JS. The effect of axillary node dissection on survival in women
with early stage breast cancer. Am J Epidemiology. 2000;151(suppl):253.
184. Du XL, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare
claims data. Gerontologist. 2000;40(Special Issue I):344-345.
185. Du XL, Goodwin JS. Increase of Chemotherapy Use in Older Women with Breast Cancer from 1991 to 1996.
Am J Epidemiology. 2001;153(suppl):362.
186. Du XL, Goodwin JS. Using Medicare Data to Examine the Patterns of Chemotherapy Use for Older Women with
Breast Cancer. Am J Epidemiology. 2001;153(suppl):836.
187. Otiniano ME, Du XL, Ray LA, Markides KS. The effect of diabetes combined with stroke on physical
impairment and mortality in elderly Hispanics. Gerontologist. 2001;41(Issue I):249.
188. Du XL, Goodwin JS. Increase of chemotherapy use in older women with breast cancer from 1991 to 1996.
Gerontologist. 2001;41(Special Issue I):337.
189. Otiniano ME, Du XL, Ottenbacher K, Black SA, Markides KS. Lower Extremity Amputations in Diabetic
Mexican American Elders: Incidence, Prevalence and Predictive Factors. Journal of the American Geriatrics
Society. 2002;50(4, supplement):S68.
190. Otiniano ME, Du XL, Ottenbacher K, Markides KS. The Effect of Diabetes Combined with Stroke on Disability,
Self-rated Health and Mortality in Older Mexican Americans: Results from the Hispanic EPESE. J Am Geriatric
Society. 2002;50(4, supplement):S69.
191. Otiniano ME, Du XL, Ottenbacher K, Black SA, Markides KS. Lower Extremity Amputations in Diabetic
Mexican American Elders: Incidence, Prevalence and Predictive Factors. Diabetes. 2002;51(supplement 2):A18.
192. Otiniano ME, Du XL, Ottenbacher K, Markides KS. The Effect of Diabetes Combined with Stroke on Disability,
Self-rated Health and Mortality in Older Mexican Americans: Results from the Hispanic EPESE. Diabetes.
2002;51(supplement 2):A235.
193. Otiniano ME, Du XL, Ray LA, Ottenbacher K, Markides KS. Heart Attack in Mexican American Elders:
Examination of Incidence, Prevalence, and 7-year Mortality. Gerontologist. 2002;42(Special Issue I):300.
194. Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between Consensus Recommendations and
Actual Community Use of Chemotherapy in Women with Breast Cancer. Gerontologist. 2002;42(Special Issue
I):190-191.
195. Otiniano ME, Markides KS, Ottenbacher K, Ray LA, Du XL. Self-Reported Diabetic Complications and 7-year
Mortality in Mexican American Elders: Findings from a Community-Based Study of Five Southwestern States. J
Am Geriatrics Society. 2003;51(4, supplement):S56.
C.V. for Xianglin Du, Ph.D.
Page 32 of 40
196. Du XL, Jones D, Goodwin J. Evidence of real-world effectiveness of adjuvant chemotherapy for node-positive
operable breast cancer in old women. Am J Epidemiology. 2003;157(suppl):148.
197. Du XL, Jones DV. Efficacy and effectiveness of adjuvant chemotherapy in old women with node-positive
operable breast cancer. Gerontologist. 2003;43(Special Issue I):141.
198. Cormier JN, Xing Y, Ding M, Ross M, Lee J, Mansfield P, Gershenwald J, Du XL. Population based assessment
of surgical treatment trends for melanoma patients. J Clin Oncol (Meeting Abstracts) 2005;23(June
supplement):7509.
199. Otiniano ME, Ray L, Du XL, Eschbach K, Markides K, Wong R. Migration and Diabetes Control in adult
Mexican men. Journal of the American Geriatrics Society. 2006;54(S4):C43.
200. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial Disparities
and Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage Prostate
Cancer. AcademyHealth Annual Meeting, June 25-27, 2006, Seattle, WA:
http://www.academyhealth.org/arm/awards/abstracts.htm.
201. Hosain M, Sanderson M, Du XL, Chan W, Strom S. Racial/Ethnic differences in prostate cancer screening
between Caucasians and Hispanics. 98th American Association for Cancer Research annual meeting, Apr 14-18,
2007; Los Angeles, CA, http://www.aacrmeetingabstracts.org/content/vol2007/1_Annual_Meeting/index.dtl.
202. Zhou Y, Wang H, Zhang Y, Du X, Kwak L, Romaguera J, Wang M. Trend and geographic variations in the
incidence of mantle cell lymphoma in the United States from 1975 to 2003. Proc ASCO. 2007;25(18S):8091.
203. Zhou Y, Wang H, Zhang Y, Du XL, Romaguera J, Wang M. Trend and Geographic Variations in the Incidence
of Mantle Cell Lymphoma in the United States from 1975 to 2003. ASCO Annual meeting, 2007, #9091:
http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts.
204. Wang M, Zhou Y, Wang H, Yi Q, Zhang Y, Alexanian R, Kwak L, Du X. Trend and geographic variations in the
incidence of Waldenstrom’s Macroglobulinemia in the United States over 17 years from 1988 to 2004.
American Society of Hematology, 49th Annual Meeting, 2007, http://www.abstracts2view.com/hem07/.
205. Zhou Y, Wang H, Du X, Yi Q, Zhang Y, Romaguera J, Wang M. Trend and geographic variations in the
incidence of mantle cell lymphoma in the United States over 30 years from 1975 to 2004. American Society of
Hematology, 49th Annual Meeting, 2007, http://www.abstracts2view.com/hem07/.
206. Du XL, Fang S, Meyer TE. Impact of Treatment and Socioeconomic Status on Racial Disparities in Survival
among Older Women with Breast Cancer. AcademyHealth annual meeting, Orlando, FL, June 3-5, 2007,
http://www.academyhealth.org/2007/abstracts/posters.pdf.
207. Rohatgi N, Du XL, Coker AL, Moye L, Wang M, Fang S. Chemotherapy increases survival in patients with
multiple myeloma. Nature Clinical Practice ONCOLOGY. 2008;5(1).
208. White A, Liu CC, Xia R, Burau KD, Cormier JN, Chan W, Du XL. Racial Disparities & Trends in the Receipt of
Standard Therapy for Colorectal Cancer in a Large Cohort of African Americans & Caucasians Aged 65 Years &
Older. AcademyHealth annual meeting, Washington DC, June 8-10, 2008,
http://www.academyhealth.org/2008/posterabstracts.pdf.
209. Davila JA, Morgan RO, Richardson P, Du XL, McGlynn KA, El-Serag HB. Utilization of Screening for
Hepatocellular Carcinoma in the United States. Digestive Disease Week 2008, San Diego, CA, P-782:
http://download.abstractcentral.com/ddw2008/myddw2008/782.html.
210. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Physician Characteristics are
Significantly Associated with Screening for Hepatocellular Carcinoma in the United States. International Liver
Cancer Association Annual Conference, Chicago, IL, 2008, P-076: http://www.ilca-
online.org/images/conference_area/pdf/ILCA2008_BookofAbstracts.pdf.
211. Song S, Burau KD, Fang S, Wang H, Du XL, Wang L. Ethnic Variations in Diagnosis, Treatment,
Socioeconomic Status and Survival in a Large Population-Based Cohort of Elderly Patients with Non-Hodgkin’s
Lymphoma.Amercian Society of Hematology 50th Annual Meeting, San Francisco, December 6-9, 2008.
http://ash.confex.com/ash/2008/webprogram/Paper1653.html.
212. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Outcomes of Screening for
Hepatocellular Carcinoma in the United States. Digestive Disease Week, Chicago, IL, May 30-June 4, 2009, P-
739. http://myddw2009.bdmetrics.com/SOW-26650830/739-Outcomes-of-Screening-for-Hepatocellular-
Carcinoma-in-the-United-States/Overview.aspx.
213. White A, Vernon SW, Franzini L, Du XL. Racial/ethnic disparities and trends in screening for colorectal cancer
among Medicare beneficiaries with cancer and those without cancer in SEER areas, 1992–2002. Cancer Prev Res
2010;3(1 Suppl):B32.
C.V. for Xianglin Du, Ph.D.
Page 33 of 40
214. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Use of white blood cell growth factors and risk of acute
myeloid leukemia or myelodysplastic syndrome among elderly non-Hodgkin's lymphoma patients. Cancer Prev
Res 2010;3(1 Suppl):B129.
215. White A, Vernon SW, Franzini L, Du XL. Disparities in Colorectal Cancer Survival: To What Extent Are Racial
Disparities Explained by Differences in Treatment, Tumor or Hospital Characteristics? American Public Health
Association (138th annual meeting in Denver, CO, November 2010) abstracts.
http://apha.confex.com/apha/138am/webprogram/Paper218115.html.
216. Gruschkus SK, Lairson D, Dunn JK, Risser JM, Du XL. Use of white blood cell growth factors and risk of acute
myeloid leukemia or myelodysplastic syndromes among elderly non-Hodgkin's lymphoma patients. Value in
Health. 2010;13(3):page 23 (abstract # PCN1). http://onlinelibrary.wiley.com/doi/10.1111/j.1524-
4733.2010.00722_1.x/pdf.
217. Gruschkus SK, Lairson D, Dunn JK, Risser JM, Du XL. Cost-effectiveness of white blood cell growth factor use
among elderly non-Hodgkin's lymphoma patients treated with chemotherapy. Value in Health. 2010;13(3):page
38 (abstract # PCN76). http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2010.00722_1.x/pdf.
218. Sail K, Franzini L, Du XL, Lairson D. Racial disparities associated with treatment and survival in elderly
patients with early stage operable breast cancer. Value in Health. 2010;13(3):page 48 (abstract # PCN129).
http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2010.00722_1.x/pdf.
219. Sail K, Franzini L, Du XL, Lairson D. Clinical and economic outcomes associated with adjuvant chemotherapy
in elderly patients with early stage operable breast cancer. Value in Health. 2010;13(7):page A262 (abstract #
PCN60). http://download.journals.elsevierhealth.com/pdfs/journals/1098-3015/PIIS1098301511719556.pdf.
220. Panchal J, Lairson D, Chan W, Du XL. Geographic variation and socio-demographic disparity in the utilization
of oxaliplatin-containing chemotherapy in patients with stage-iii colon cancer. Value in Health. 2012;15(4):page
A233 (abstract # PCN138). http://download.journals.elsevierhealth.com/pdfs/journals/1098-
3015/PIIS1098301512013204.pdf.
221. Parikh RC, Lairson DR, Cormier JN, Du XL. Cost-Utility Analysis of Various Chemotherapy Regimens among
Elderly Ovarian Cancer Patients: A Longitudinal Cohort Study. Pharmacoepidemiology and Drug Safety. 2013;
22: (Suppl. 1), page 172 (abstract #356). http://onlinelibrary.wiley.com/doi/10.1002/pds.3512/pdf.
222. Poonawalla IB, Lairson DR, Du XL. Cost assessment of advanced ovarian cancer treatment in a large cohort of
elderly patients. Value in Health. 2014;17(3):A80 (Abstract# PCN72).
http://www.ispor.org/publications/value/VIH_17-3_final.pdf.
223. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Chemotherapy Regimens in
Elderly Patients with Stage III Colon Cancer. Presented at the International Health Economics Association
Conference, July 13-16, 2014, Dublin, Ireland. https://ihea2014.abstractsubmit.org/presentations/11767/.
224. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Chemotherapy and Targeted
Therapy for Advanced Non-Small Cell Lung Cancer in a Large Retrospective Cohort of Elderly Patients.
Presented at the International Health Economics Association (iHEA) Conference, July 12-15, 2015, Milan, Italy.
https://ihea2015.abstractsubmit.org/presentations/13118/.
225. Rajan S, Du XL, Lyman G. Cost Effectiveness of Pegfilgrastim versus Filgrastim in Elderly Breast Cancer
Patients Receiving Chemotherapy. Presented at the International Health Economics Association (iHEA)
Conference, July 12-15, 2015, Milan, Italy. https://ihea2015.abstractsubmit.org/presentations/13343/.
226. Zhang Y, Franzini L, Chan W, Xu H, Du XL. Effects of Health Insurance on Tumor Stage, Treatment, and
Survival in Large Cohorts of Patients with Breast and Colorectal Cancer. Innovations in Cancer Prevention and
Research Conference of the CPRIT, Nov. 9-10, 2015, Austin, Texas: https://s3.amazonaws.com/cprit-
assets/cprit2015/confsite/cprit2015conf_web_v1.pdf, abstract #219, page 128.
227. Liu Z, Zhang Y, Franzini L, Cormier JN, Chan W, Xu H, Du XL. Trends and Variations in Breast and Colorectal
Cancer Incidence from 1995 to 2011: A Comparative Study between Texas and SEER. Innovations in Cancer
Prevention and Research Conference of the CPRIT, Nov. 9-10, 2015, Austin, Texas:
https://s3.amazonaws.com/cprit-assets/cprit2015/confsite/cprit2015conf_web_v1.pdf, abstract #232, page 134.
228. Zhao H, Ding M, Niu J, Ho V, Zhang N, Du XL, Giordano S. Elderly Texas patients’ adherence to treatment
guidelines for regional colorectal cancer. Innovations in Cancer Prevention and Research Conference of the
CPRIT, Nov. 9-10, 2015, Austin, Texas: https://s3.amazonaws.com/cprit-
assets/cprit2015/confsite/cprit2015conf_web_v1.pdf, abstract #384, page 197.
C.V. for Xianglin Du, Ph.D.
Page 34 of 40
229. Parikh RC, Du XL, Morgan RO, Lairson DR. Treatment patterns among elderly metastatic colorectal cancer
patients - a SEER-Medicare analysis. Presented at ISPOR 20th Annual International Meeting, Philadelphia, PA,
USA, May 16-20, 2015. (abstract # PCN184). https://www.ispor.org/research_study_digest/details.asp.
230. Parikh RC, Du XL, Morgan RO, Lairson DR. Cost Effectiveness of Treatment Sequences for Elderly Metastatic
Colorectal Cancer Patients: A SEER-Medicare-Based Modelling Analysis. Value in Health. 2016;19(3):Page
A150 (abstract # PCN91). http://www.valueinhealthjournal.com/article/S1098-3015(16)01658-2/pdf.
231. Hambleton Davis CM, Shirkey BA, Moore LW, Bailey HR, Du XL, Cusick MV. 52.03 Trends in Utilizing
Laparoscopic Colorectal Surgery Over Time in 2005-2014 Using the NSQIP Database. 2017 Academic Surgical
Congress abstracts. http://www.asc-abstracts.org/abs2017/52-03-trends-in-utilizing-laparoscopic-colorectal-
surgery-over-time-in-2005-2014-using-the-nsqip-database/.
IV. Technical Reports:
232. Du XL. Epidemiology of ageing. Proceedings of Geriatrics of Anhui Gerontology Association. 1986;10-3.
233. Du XL. A cross-sectional study of activities of daily living and active life expectancy in the elderly in two
Counties of Anhui Province. MS Degree Thesis. Anhui, China: Anhui Medical School, 1987.
234. Du XL, Goodfellow J, Broughton D, Cleary R, James OFW, Parker SG. Routine outcomes
measurement in elderly patients in a geriatric day hospital. Newcastle: University of Newcastle
and CASPE Research, 1992.
235. Du XL. A community-based stroke register and case-control study of stroke and the quality of hypertension
control in northwest England. PhD Degree Dissertation. Manchester, England: University of Manchester, 1997.
V. Research presentation awards for projects involving students or post-doctoral fellows whom I advised:
1. Holmes L (DrPH student), Chan W, Jiang Z, Du XL. Influence of Androgen Deprivation Therapy on Racial Disparities
in Survival of Older Men Treated for Locoregional Prostate Cancer. Presented at the 8th Annual Health Services and
Outcomes Research Conference in Houston on November 6, 2007, and won the 1st place award in the Equity research
poster session.
2. White A (PhD student), Liu CC, Xia R, Burau KD, Cormier JN, Chan W, Du XL. Racial Disparities and Treatment
Trends in a Large Cohort of African Americans & Caucasians with Colorectal Cancer, 1991-2002. Presented at the 9th
Annual Health Services and Outcomes Research Conference in Houston on December 3, 2008, and won the 1st place
award in the Equity research poster session.
3. Nurgalieva Z (PhD student), Xia R, Liu CC, Burau KD, Hardy D, Du XL. Chemotherapy-induced Peripheral
Neuropathy in Elderly Patients with Breast, Ovarian or Lung Cancer: Findings from Large Nationwide and Population-
based Cohorts. Presented at the 9th Annual Health Services and Outcomes Research Conference in Houston on December
3, 2008, and won the 1st place award in the Patient Safety research poster session.
4. Sail K (PhD student), Franzini L, Du XL, Lairson DR. Racial Disparities Associated with Treatment and Survival in
Early Stage Operable Breast Cancer Patients. Presented at the 9th Annual Health Services and Outcomes Research
Conference in Houston on December 2, 2009, and won the 2nd place award in the Equity research poster session.
5. Nurgalieva Z (PhD student), Franzini L, Morgan R, Vernon SW, Du XL. Timely Initiation and Completion of
Chemotherapy, Ethnicity And Survival In Breast Cancer Patients. Presented at the 13th Annual Health Services &
Outcomes Research Conference: Improving the Quality of Healthcare Through Accountable Care Organizations and
Technology, on December 13, 2012 in Houston, TX, and won the 1st place award in the 'Timeliness of Care' research
poster session.
6. Poonawalla IB (PhD student), Lairson DR, Chan W, Piller LB, Du XL. Cost assessment of advanced ovarian cancer
treatment in a large cohort of elderly patients. Presented to the 19th International Society for Pharmacoeconomics and
C.V. for Xianglin Du, Ph.D.
Page 35 of 40
Outcomes Research (ISPOR) annual meeting on May 31-June 4, 2014 in Montreal, Canada, and received the poster
finalist award to be highlighted at the meeting.
7. Farias AJ (Post-doc fellow), Du XL. Racial/ethnic differences in the use and discontinuation of adjuvant endocrine
therapy by hormone-receptor status in association with mortality among breast cancer patients enrolled in Medicare Part
D. This abstract (#1524) was one of the 16 top-ranked abstracts (out of 183) for 2017 ASPO (American Society of
Preventive Oncology) conference and has been accepted for publication in the journal Cancer Epidemiology, Biomarkers
& Prevention.
8. Farias AJ (Post-doc fellow) received the Calle/Rodriguez Memorial Minority Travel Award by the American Cancer
Society. This award is given to the two top ranking abstracts and each award will cover $1,500 of travel related expenses
to the ASPO 2017 meeting in Seattle, WA. The abstract was: Farias AJ, Du XL. Racial/ethnic differences in the use and
discontinuation of adjuvant endocrine therapy by hormone-receptor status in association with mortality among breast
cancer patients enrolled in Medicare Part D.
VI. Media Reports on Research Findings:
1. In May 2001, the official journal of the American Cancer Society Cancer issued a press release for our article (Du XL,
Goodwin JS. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer. May 1,
2001;92(4):730-737). The national news magazine Hem/Onc today published a long story entitled “Chemotherapy use
increases in elderly patients” in November 2001 Issue. It was also reported in Internal Medicine News magazine etc.
2. In September 2002, the U.S. Department of Defense Era of Hope National Breast Cancer Program meeting issued a
press release for my research project funded by this program, entitled “Axillary dissection and survival of women after
breast-conserving surgery for early-stage breast cancer”. Several radio news stations and medical news magazines,
including Ivanhoe Broadcast News, Inc., and International Medical News, reported the findings. It was also highlighted in
the UTMB Newsletter Impact on December 16, 2002.
3. In January 2003, the American College of Physicians and Annals of Internal Medicine issued a press release regarding
our article that was published in Annals of Internal Medicine, January 21st issue, 2003 (Du XL, Key CR, Osborne C,
Mahnken JD, Goodwin JS. Discrepancy between consensus recommendations and actual community use of adjuvant
chemotherapy in women with breast cancer. Ann Intern Med. 2003;138:90-97). The UTMB Public Affairs Office also
issued a longer press release regarding this article. The NBC and ABC news, CNN headline news, the New York Times
(January 28, 2003), and TIME Magazine (February 3, 2003) reported the findings.
4. An internationally renowned oncology researcher, Dr. L. Balducci, was invited by the Journal editors for writing an
editorial specifically on our research article published in the September issue of 2005 in the Journal of Gerontology
(Medical Sciences), an official journal of the Gerontologic Society of America. This editorial praised the important
contributions of our research. In his editorial, Dr. Balducci wrote “Du and colleagues have provided an important
contribution to the field by: (a) demonstrating that adjuvant chemotherapy does not have a substantial impact in breast
cancer-related mortality for women aged 70 and older; and (b) providing a demonstration of a very creative use of the
SEER-Medicare database.”
5. In February 2006, the official journal of the American Cancer Society Cancer issued a press release for our article (Du
XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial Disparity and
Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage Prostate Carcinoma:
Findings From a Large Community-Based Cohort. Cancer. Published Online: February 13, 2006. Print Issue Date: March
15, 2006). The widely used wire service HEALTHDAY today and Prostate Cancer Foundation reported the findings
entitled “Poverty Behind Poor Prostate Cancer Outcomes in Black Men” By Meryl Hyman Harris on February 13, 2006.
The findings were also reported in WebMD (2/13/06), medpageTODAY (2/13/06), Urology Times (2/16/06), Patient
Health International (2/20/06), Physician’s Weekly (June 5, 2006), and many other medical professional/foundation
websites.
C.V. for Xianglin Du, Ph.D.
Page 36 of 40
6. The abstract entitled “Racial Disparities and Socioeconomic Status in Association with Survival in Older Men with
Local/Regional Stage Prostate Cancer” by Du and colleagues at the UT School of Public Health has been selected for the
best abstracts award (out of 1,646 abstract submissions) at the Annual Conference of the national AcademyHealth on June
25-27, 2006, in Seattle, WA. AcademyHealth is a leading international professional society for advancing research, policy
and practice, and a premier forum for health services research and for Agency for Healthcare Research and Quality
(AHRQ). The detail is available at http://www.academyhealth.org/arm/awards/abstracts.htm. The authors were invited to
present the paper at a special session together with the article of the year.
7. On April 23, 2007, the official journal of the American Cancer Society Cancer issued a press release for our article (Du
XL, Meyer TE, Franzini L. Meta-Analysis of Racial Disparities in Survival in Association with Socioeconomic Status
among Men and Women with Colon Cancer. Cancer. 2007 June 1;109:2161-70). The findings were also reported in
ScienceDaily.com (4/23/07), ASPH (Association of Schools of Public Health) Friday Letter (4/27/07), WebMD, ACS
(American Cancer Society) website, MedicalNewsToday, Science Daily (4/23/07), Scientific American.com (4/24/07),
and Distinctions of the UTHSC-H (July 2007).
8. In October, 2007, our article (Rohatgi N (MS student in epi), Du XL, Coker AL, Moye L, Wang M, Fang S.
Chemotherapy and Survival for Patients with Multiple Myeloma: Findings from a Large Nationwide and Population-
Based Cohort. American Journal of Clinical Oncology. 2007 Oct;30(5):540-548.) was selected by the Nature: Clinical
Practice Oncology for Research Highlights (January 2008 issue), and by the Lancet Oncology for news item.
9. In January 2007, our article “Racial Disparities and Trends in Radiation Therapy After Breast-Conserving Surgery for
Early-Stage Breast Cancer in Women, 1992 to 2002” in Ethnicity & Diseases was selected as a featured article in the
journal and its abstract was selected to be published in New England Journal of Medicine (in the issue of 2007).
10. On July 9, 2008, the official journal of the American Cancer Society Cancer issued a press release for our article
entitled “Incidence Trends of Mantle Cell Lymphoma in the United States Between 1992 and 2004” (Published Online:
July 9, 2008. Print Issue Date: August 15, 2008). The findings were also reported in HealthDay website
(http://www.healthday.com/Article.asp?AID=617214) on July 18, 2008.
11. The August 2008 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality
(AHRQ) published an article entitled “Poorer treatment and lower socioeconomic status may underlie ethnic disparities in
breast cancer survival”, that reported the findings of our study (Du XL, Fang S, Meyer TE. Impact of Treatment and
Socioeconomic Status on Racial Disparities in Survival among Older Women with Breast Cancer. Am J Clin Oncol. April
2008;31:125-132). See weblink: http://ahrq.hhs.gov/research/aug08/0808RA3.htm.
12. The November 2008 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality
(AHRQ) published an article entitled “Less receipt of effective treatment by elderly black women with ovarian cancer
may underlie their poorer survival”, that reported the findings of our study (Du XL, et al. Ethnic Differences in
Socioeconomic Status, Diagnosis, Treatment and Survival Among Older Women with Epithelial Ovarian Cancer.
International Journal of Gynecological Cancer. 2008;18:660-669). See weblink:
http://www.ahrq.gov/research/nov08/1108RA7.htm.
13. The November 2008 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality
(AHRQ) published an article entitled “Prostate removal is better than radiation or watchful waiting for elderly men with
local/regional prostate cancer”, that reported the findings of our study (Liu L, et al. Long-Term Survival after Radical
Prostatectomy Compared to Other Treatments in Older Men with Local or Regional Prostate Cancer. Journal of Surgical
Oncology. 2008;97:583-591). See weblink: http://www.ahrq.gov/research/nov08/1108RA15.htm.
14. On October 20, 2008, the official journal of the American Cancer Society Cancer issued a press release for our article
(Wang M, Burau KD, Fang S, Wang H, Du XL. Ethnic Variations in Diagnosis, Treatment, Socioeconomic Status and
Survival in Elderly Patients with Non-Hodgkin’s Lymphoma. Cancer. Online published October 20, 2008, print issue
December 1, 2008). The findings were reported in websites:
C.V. for Xianglin Du, Ph.D.
Page 37 of 40
Medscape Today (10/23/08), Reuters (10/21/08), American Cancer Society (10/20/08), Scientific American (10/21/08),
Science Daily (10/27/08), HealthDay (10/20/08), Medical Breakthroughs (10/21/08), ASCO (10/21/08), UTHSC-H
(10/20/08), and in numerous television websites (10/21/08) (http://us.cisionpoint.com/ListPage.aspx?id=64306815).
15. The February 2009 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality
(AHRQ) published an article entitled “Older white men are most likely to be diagnosed with mantle cell lymphoma”,
which reported the findings of our study (Incidence trends of mantle cell lymphoma in the United States between 1992
and 2004. Zhou Y, et al, Cancer. 2008, August 15; 13(4):791-798). See weblink:
http://www.ahrq.gov/research/feb09/0209RA16.htm.
16. On April 13, 2009, the official journal of the American Cancer Society Cancer issued a press release for our article
entitled “Racial Disparities and Treatment Trends in a Large Cohort of Elderly Black and White Patients with Non-Small
Cell Lung Cancer” (Published Online: April 13, 2009. Print Issue Date: May 15, 2009). The findings were also reported in
HealthDay website (4/13/09), UTHSC-H (4/13/09) and about 50 media outlets across the country. This study was also
reported in the October 2009 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and
Quality (AHRQ).
17. On April 27, 2009, the official journal of the American Cancer Society Cancer issued a press release for our article
entitled “Review of Major Adverse Effects of Androgen Deprivation Therapy in Men with Prostate Cancer” (Published
Online:, 2009. Print Issue Date: June 1, 2009). The findings were also reported in websites such as ScienceDaily
(4/27/2009).
18. The July 2009 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality
(AHRQ) published an article entitled “Studies explore survival and treatment disparities among black and white elderly
patients with cancer”, which reported the findings of our two studies (Ethnic variation in diagnosis, treatment,
socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma."
(Cancer. 2008;113:3231-41) and Racial disparities and treatment trends in a large cohort of elderly African Americans
and Caucasians with colorectal cancer, 1991 to 2002." (Cancer. 2008;113:3400-9). See Link:
http://www.ahrq.gov/research/jul09/0709RA7.htm.
19. On August 17, 2009, our article “Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Chan W, Hardy D, Burau KD. Cardiac
Toxicity Associated with Anthracycline-Containing Chemotherapy in Older Women with Breast Cancer. Cancer. 2009
Aug 11; [Epub ahead of print]” was featured on our MDLinx.com site today. See Link:
http://www.mdlinx.com/hemeonclinx/news-article.cfm/2840535.
20. The October 2009 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Blacks are
less likely than whites to receive lung cancer treatments”, which reported the findings of our study (Hardy D, Liu CC, Xia
R, Cormier JN, Chan W, White A, Burau KD, Du XL. Racial Disparities and Treatment Trends in a Large Cohort of
Elderly Black and White Patients with Non-Small Cell Lung Cancer. Cancer. 2009;115:2199-2211). See Link:
http://www.ahrq.gov/research/oct09/1009RA17.htm.
21. The November 2009 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Older
black women with breast cancer do not receive beneficial chemotherapy as often as white women”, which reported the
findings of our study (Bhargava A, Du XL. Racial and Socioeconomic Disparities in Adjuvant Chemotherapy for Node-
Positive Operable Breast Cancer in Older Women. Cancer. 2009 July 1;115:2999-3008). See Link:
http://www.ahrq.gov/research/nov09/1109RA2.htm.
22. The December 2009 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Men with
prostate cancer who receive androgen deprivation therapy are at elevated risk of bone fractures, cardiovascular mortality,
and diabetes”, which reported the findings of our study on “Review of major adverse effects of androgen-deprivation
therapy in men with prostate cancer” (Cancer. 2009;115:2388-2399). See weblink:
http://origin.www.ahrq.gov/research/dec09/1209RA16.htm.
C.V. for Xianglin Du, Ph.D.
Page 38 of 40
23. The April 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Chemotherapy
that contains anthracyclines is associated with later cardiac illness in breast cancer patients”, which reported the findings
of our study on “Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast
cancer” (Cancer. 2009;115:5296-5308.). See weblink: http://www.ahrq.gov/research/apr10/0410RA8.htm.
24. The June 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Nonplatinum
chemotherapy agents more likely to lead to hospitalizations for older women with ovarian cancer”, which reported the
findings of our study on “Risk of hospitalizations associated with adverse effects of chemotherapy in a large community-
based cohort of elderly women with ovarian cancer” (International Journal of Gynecological Cancer. 2009;19:1314-
1321). See weblink: http://www.ahrq.gov/research/jun10/0610RA5.htm.
25. On July 12, 2010, the official journal of the American Cancer Society Cancer issued a press release for our article
entitled “Disparities in Colorectal Cancer Survival: To What Extent Are Racial Disparities Explained by Differences in
Treatment, Tumor or Hospital Characteristics?” (Published Online: July 12, 2010. Print Issue Date: August 15, 2010). The
findings were also reported in UTHSC-H (UTHealth) website (7/12/10), NewsWise
(http://www.newswise.com/)(7/12/10), USNEWs-HealthDay (7/16/10), and ASPH Friday Letter (7/23/10).
26. The September 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Blacks
with lung cancer have higher mortality rates than whites”, which reported the findings of our study on “Racial disparities
and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients” (Cancer. 2009;115: 4807-
4818). See weblink: http://www.ahrq.gov/research/sep10/0910RA6.htm.
27. The September 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Benefits
of chemotherapy for elderly patients with lung cancer must be weighed against risk of long-term toxicities”, which
reported the findings of our study on “Chemotherapy-associated toxicity in a large cohort of elderly patients with non-
small cell lung cancer” (Journal of Thoracic Oncology. 2010;5:90-98). See weblink:
http://www.ahrq.gov/research/sep10/0910RA29.htm.
28. The February 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Poorer
patients less likely to receive specific treatment for head and neck cancer”, which reported the findings of our study on
“Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005”
(Cancer. 2010;116:3505-12). See weblink: http://www.ahrq.gov/research/feb11/0211RA25.htm.
29. The March 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Colony-
stimulating factor is effective in reducing infection for elderly patients with non-Hodgkin's lymphoma on chemotherapy”,
which reported the findings of our study on “Comparative Effectiveness of White Blood Cell Growth Factors on
Neutropenia, Infection, and Survival in Older People with Non-Hodgkin's Lymphoma Treated with Chemotherapy” (J Am
Geriatr Soc. 2010;58(10):1885-95). See weblink: http://www.ahrq.gov/research/mar11/0311RA11.htm.
30. The March 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Blacks have
worse colorectal cancer survival rates than whites”, which reported the findings of our study on “Disparities in Colorectal
Cancer Survival: To What Extent Are Racial Disparities Explained by Differences in Treatment, Tumor or Hospital
Characteristics?” (Cancer. 2010;116(19):4622-31). See weblink: http://www.ahrq.gov/research/mar11/0311RA19.htm.
31. The March 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Medicare-
insured patients with head or neck cancer differ little in mortality risk because of race or ethnicity”, which reported the
findings of our study on “Racial/Ethnic Disparities in Socioeconomic Status, Diagnosis, Treatment and Survival among
Medicare-insured Men and Women with Head and Neck Cancer” (J Health Care Poor Underserved. 2010;21(3):913-
930). See weblink: http://www.ahrq.gov/research/mar11/0311RA20.htm.
32. On May 5, 2011, American Association for Cancer Research (AACR) issued a press release for our article (White A,
Vernon SW, Franzini L, Du XL. Racial and Ethnic Disparities in Colorectal Cancer Screening Persisted Despite
Expansion of Medicare's Screening Reimbursement. Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):811-7):
C.V. for Xianglin Du, Ph.D.
Page 39 of 40
http://www.aacr.org/home/public--media/aacr-in-the-news.aspx?d=2366. The findings were also reported in UTHealth,
HealthDay News, ScienceDaily, MedicalNews, MDNews, and HealthWorldWeb.
33. The June 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Chemotherapy
and radiation therapy for lung cancer linked to cardiac disorders”, which reported the findings of our study published in
Annals of Oncology. 2010 Sep;21(9):1825-33. See weblink: http://www.ahrq.gov/research/jun11/0611RA17.htm.
34. The September 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Minority
patients with nonsmall-cell lung cancer are less likely to receive hospice services than whites”, which reported the
findings of our study published in Cancer. 2011;117 (7):1506-1515. See weblink:
http://www.ahrq.gov/research/sep11/0911RA13.htm.
35. Our research article “Racial disparities in the use of hospice services according to geographic residence and
socioeconomic status in an elderly cohort with nonsmall cell lung cancer” has been named as one of the top clinical
cancer research advances of the year and featured in 2011 Clinical Cancer Advances: ASCO’s Annual Report on
Progress Against Cancer (pages 30-32), which was published online on December 5, 2011 in the Journal of Clinical
Oncology and is available from www.Cancer.Net.
36. The September 2012 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Several
factors influence completion of chemotherapy in elderly patients with stage-III colon cancer”, which reported the findings
of our study published in Medical Oncology. 2011;28:1062-74. See weblink:
http://www.ahrq.gov/research/sep12/0912RA12.htm.
37. The November 2012 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled
“Radiation therapy linked to dry mouth in elderly patients with head and neck cancers”, which reported the findings of our
study published in American Journal of Therapeutics. 2011;18: 206-215. See weblink:
http://www.ahrq.gov/research/nov12/1112RA10.htm.
38. The UTSPH (1/23/2013), ASPH Friday Letter (1/26/2013), and News on the Go (1/29/2013) reported our recent
research findings funded by the AHRQ: “UTSPH researchers compare the effectiveness of chemotherapy options for
ovarian cancer”. See weblink: https://sph.uth.edu/2013/01/utsph-researchers-compare-the-effectiveness-of-chemotherapy-
options-for-ovarian-cancer/, http://fridayletter.asph.org/press.cfm?FL_Index=1762, and
https://inside.uthouston.edu/notg/index.htm.
39. The January 2013 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Elderly
colon cancer patients receiving chemotherapy after surgery are at risk for various toxicities”, which reported the findings
of our study published in American Journal of Clinical Oncology. 2012;35:228-236. See weblink:
http://www.ahrq.gov/legacy/research/jan13/0113RA17.htm.
40. The June 2013 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Combination
chemotherapy increases the risk for adverse events in elderly patients with colorectal cancer”, which reported the findings
of our study published in Annals of Oncology. 2012;23:1053-11. See weblink:
http://www.ahrq.gov/news/newsletters/research-activities/13jun/0613RA40.html.
41. The ‘MedicalResearch.Com’ reported (11/13/2014) our recent research findings funded by the AHRQ and CPRIT:
“Colon Cancer: Improved Screening and Chemotherapy Contribute To Improved Survival”. See weblink:
http://medicalresearch.com/cancer-_-oncology/colon-
cancer/colon_cancer_improved_screening_and_chemotherapy_contribute_to_improved_survival/8950/#more-8950.
42. On August 11, 2015, UTHealth issued a press release (https://www.uth.edu/media/story.htm?id=fcfafe64-039f-4de7-
baaa-4e0e93858256) for our research article (Du XL, et al. Comparative Effectiveness of Chemotherapy Regimens in
Prolonging Survival for Two Large Population-based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-
2009. J Am Geriatrics Society. 2015 July 22). The findings were reported in 35 news outlets, including
HealthinAging.org, Science Daily, MedicalXPress.com, NursingTime.Net, ScienceNewsLine, TheStatesman,
C.V. for Xianglin Du, Ph.D.
Page 40 of 40
ETHealthWorld.com, AJMC-ManagedMarketsNetwork, News-Medical.net, Yahoo News, Dallas Sun,
MedicalNewsToday.com, thenewsworthly.com, inquisitr.com, breastcancer.org, and ASPPH Newsletters.
43. On October 31, 2016, UTHealth issued a press release (https://www.uth.edu/media/story.htm?id=d18c5243-ecc0-
4e63-9469-0f26172f217a) for our research article (Farias AJ, Du XL. The association between out-of-pocket costs,
race/ethnicity, and adjuvant endocrine therapy adherence among Medicare patients with breast cancer. Journal of Clinical
Oncology. 2016 Oct 31). The findings were reported in 45 news outlets, including Reuters Health (11/1/16), ASCO’s
Cancer in the News (11/1/16), FoxNewsHealth (11/1/16), ScienceDaily (11/1/16), Hospital CFO (11/1), HiTechDays
(11/3/16), ASPPH News (11/3/16), and The Insider (11/7/16).